| 1 | Point-of-care testing: state-of-the art and perspectives | 2.4 | 51 | Citations (PDF) |
| 2 | EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) survey on cybersecurity | 2.4 | 3 | Citations (PDF) |
| 3 | Mortality for lip and oral cavity cancers during the <scp>COVID</scp>‐19 pandemic | 2.6 | 1 | Citations (PDF) |
| 4 | EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) recommendations for reinforcing cyber-security and managing cyber-attacks in medical laboratories | 2.4 | 3 | Citations (PDF) |
| 5 | Generative artificial intelligence (AI) for reporting the performance of laboratory biomarkers: not ready for prime time | 2.4 | 3 | Citations (PDF) |
| 6 | The impact of the COVID-19 pandemic on diabetes-related mortality | 1.4 | 2 | Citations (PDF) |
| 7 | Oh no, all we needed was monkeypox! | 2.9 | 1 | Citations (PDF) |
| 8 | Mpox (monkeypox) diagnostic kits – September 2024 | 1.4 | 6 | Citations (PDF) |
| 9 | Reply to increase in diabetic deaths during COVID-19 pandemic. Some comments | 1.4 | 0 | Citations (PDF) |
| 10 | Multi-cancer early detection: searching for evidence | 2.4 | 2 | Citations (PDF) |
| 11 | Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond | 2.6 | 1 | Citations (PDF) |
| 12 | Artificial intelligence in the pre-analytical phase: State-of-the art and future perspectives | 1.9 | 21 | Citations (PDF) |
| 13 | Effect of syringe underfilling on the quality of venous blood gas analysis | 1.4 | 2 | Citations (PDF) |
| 14 | Personalized laboratory medicine in the digital health era: recent developments and future challenges | 2.4 | 17 | Citations (PDF) |
| 15 | Editorial Compilation XIV | 2.6 | 0 | Citations (PDF) |
| 16 | Classification Criteria for the Antiphospholipid Syndrome: Not the Same as Diagnostic Criteria for Antiphospholipid Syndrome | 2.6 | 16 | Citations (PDF) |
| 17 | Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman–Diamond syndrome cells | 2.4 | 10 | Citations (PDF) |
| 18 | International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls | 2.6 | 4 | Citations (PDF) |
| 19 | Updated statistics on Influenza mortality | 1.4 | 3 | Citations (PDF) |
| 20 | Clinical assessment of Ortho VITROS SARS-CoV-2 antigen chemiluminescence immunoassay | 1.4 | 1 | Citations (PDF) |
| 21 | Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i | 2.4 | 6 | Citations (PDF) |
| 22 | Cardiac troponin T (cTnT) assessment using incompletely filled K 2 EDTA blood tubes is reliable | 0.8 | 0 | Citations (PDF) |
| 23 | Diagnostic value of D-dimer in differentiating multisystem inflammatory syndrome in Children (MIS-C) from Kawasaki disease: systematic literature review and meta-analysis | 1.4 | 4 | Citations (PDF) |
| 24 | Unfractionated heparin: optimizing laboratory monitoring and reducing unwanted interference in everyday hemostasis test practice | 0.6 | 0 | Citations (PDF) |
| 25 | Venous Thrombosis in Airborne Viral Infections: Is Coronavirus Disease 2019 now Any Different from Influenza? | 2.6 | 1 | Citations (PDF) |
| 26 | The impact of physiological variations on personalized reference intervals and decision limits: an in-depth analysis | 2.4 | 14 | Citations (PDF) |
| 27 | Editorial Compilation—XV | 2.6 | 0 | Citations (PDF) |
| 28 | Pearls and Pitfalls in the Measurement of Direct Oral Anticoagulants | 2.6 | 5 | Citations (PDF) |
| 29 | Historical Comparison Between the Death Rate for Spanish Flu and Coronavirus Disease 2019 in Italy | 3.8 | 2 | Citations (PDF) |
| 30 | SARS-CoV-2 is here to stay: do not lower our guard | 2.4 | 2 | Citations (PDF) |
| 31 | Are there any reasons to use three levels of quality control materials instead of two and if so, what are the arguments? | 2.4 | 1 | Citations (PDF) |
| 32 | Red blood cell distribution width (RDW) reflects disease severity in patients with carbon monoxide poisoning: systematic literature review and meta-analysis | 1.3 | 5 | Citations (PDF) |
| 33 | Recommendations for blood sampling in emergency departments from the European Society for Emergency Medicine (EUSEM), European Society for Emergency Nursing (EuSEN), and European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase. Executive summary | 2.4 | 8 | Citations (PDF) |
| 34 | Analysis of thicknesses of blood collection needle by scanning electron microscopy reveals wide heterogeneity | 1.4 | 1 | Citations (PDF) |
| 35 | Effect of exogenous lipids contamination on blood gas analysis | 0.2 | 0 | Citations (PDF) |
| 36 | Efecto de la contaminación por lípidos exógenos en la gasometría | 0.2 | 0 | Citations (PDF) |
| 37 | Diurnal and day-to-day biological variation of salivary cortisol and cortisone | 2.4 | 3 | Citations (PDF) |
| 38 | Recent mortality rates due to complications of medical and surgical care in the US | 1.4 | 1 | Citations (PDF) |
| 39 | Mortality of Laryngeal Cancer before and during the COVID-19 Pandemic | 1.0 | 1 | Citations (PDF) |
| 40 | Should APTT become part of thrombophilia screening? | 1.4 | 0 | Citations (PDF) |
| 41 | Omicron or no longer omicron: That is the question | 1.2 | 0 | Citations (PDF) |
| 42 | <i>Clinical Chemistry Laboratory Medicine</i> in the post-acute COVID-19 era | 2.4 | 1 | Citations (PDF) |
| 43 | Investigating the incremental value of urine sediment reporting in emergency medicine with a Sysmex UN urinalysis system | 0.2 | 1 | Citations (PDF) |
| 44 | Relationship between COVID-19 pandemic and early mortality for malignant prostate cancer | 0.5 | 0 | Citations (PDF) |
| 45 | Preanalytical Impact of Incomplete K2EDTA Blood Tube Filling in Molecular Biology Testing | 3.0 | 1 | Citations (PDF) |
| 46 | Effects of recombinant SARS-CoV-2 spike protein variants on red blood cells parameters and red blood cell distribution width | 3.9 | 7 | Citations (PDF) |
| 47 | A vision to the future: value-based laboratory medicine | 2.4 | 28 | Citations (PDF) |
| 48 | What We Know (and Do not Know) Regarding the Pathogenesis of Pulmonary Thrombosis in COVID-19 | 2.6 | 15 | Citations (PDF) |
| 49 | D-dimer: old dogmas, new (COVID-19) tricks | 2.4 | 44 | Citations (PDF) |
| 50 | Towards 50 years of platelet function analyser (PFA) testing | 2.4 | 28 | Citations (PDF) |
| 51 | β-sitosterol ameliorates inflammation and Pseudomonas aeruginosa lung infection in a mouse model | 0.8 | 14 | Citations (PDF) |
| 52 | Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept | 2.4 | 6 | Citations (PDF) |
| 53 | Standardization and harmonization in laboratory medicine: not only for clinical chemistry measurands | 2.4 | 22 | Citations (PDF) |
| 54 | Estimating the worldwide burden of health loss due to hearing loss | 0.3 | 13 | Citations (PDF) |
| 55 | An overview of the most important preanalytical factors influencing the clinical performance of SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) | 2.4 | 13 | Citations (PDF) |
| 56 | Time to address quality control processes applied to antibody testing for infectious diseases | 2.4 | 17 | Citations (PDF) |
| 57 | <i>Clinical Chemistry and Laboratory Medicine</i> celebrates 60 years – narrative review devoted to the contribution of the journal to the diagnosis of SARS-CoV-2 | 2.4 | 11 | Citations (PDF) |
| 58 | Uncontrolled confounding in COVID-19 epidemiology | 1.4 | 11 | Citations (PDF) |
| 59 | Diagnostic accuracy of Siemens SARS-CoV-2 Antigen (CoV2Ag) chemiluminescent immunoassay for diagnosing acute SARS-CoV-2 infection: a pooled analysis | 2.4 | 4 | Citations (PDF) |
| 60 | Type 2 Diabetes Related Mitochondrial Defects in Peripheral Mononucleated Blood Cells from Overweight Postmenopausal Women | 3.5 | 7 | Citations (PDF) |
| 61 | Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays | 2.4 | 4 | Citations (PDF) |
| 62 | A Simple Epidemiologic Model for Predicting Impaired Neutralization of New SARS-CoV-2 Variants | 3.0 | 5 | Citations (PDF) |
| 63 | Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation | 4.5 | 9 | Citations (PDF) |
| 64 | Deciphering the role of monocyte and monocyte distribution width (MDW) in COVID-19: an updated systematic review and meta-analysis | 2.4 | 14 | Citations (PDF) |
| 65 | Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly | 3.0 | 4 | Citations (PDF) |
| 66 | Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test | 1.4 | 0 | Citations (PDF) |
| 67 | Nationwide analysis of COVID-19 death rate throughout the pandemic in Italy | 0.7 | 2 | Citations (PDF) |
| 68 | Pooled analysis of efficacy of the fourth mRNA-based COVID-19 vaccine dose in eliciting anti-SARS-CoV-2 serum antibody response in the general immunocompetent population | 0.2 | 0 | Citations (PDF) |
| 69 | Infodemiological analysis of suicide intentions in the US before and during the COVID-19 pandemic | 3.3 | 1 | Citations (PDF) |
| 70 | Cellular immunity against SARS-CoV-2 depends on the serological status | 2.9 | 2 | Citations (PDF) |
| 71 | Increased Prevalence of Pulmonary Embolism during the COVID-19 Pandemic in the US: An Infodemiological Analysis | 1.1 | 0 | Citations (PDF) |
| 72 | Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity | 2.4 | 7 | Citations (PDF) |
| 73 | Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing | 2.4 | 10 | Citations (PDF) |
| 74 | Response to Tony Badrick regarding “Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2): 205–212 by” | 2.4 | 1 | Citations (PDF) |
| 75 | Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay | 2.4 | 3 | Citations (PDF) |
| 76 | Serum Vitamin D Concentration Is Lower in Patients with Tinnitus: A Meta-Analysis of Observational Studies | 3.0 | 1 | Citations (PDF) |
| 77 | Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine: a proof-of-concept study | 2.4 | 1 | Citations (PDF) |
| 78 | Clinical pearls and pitfalls of SARS-CoV-2 serology | 2.9 | 0 | Citations (PDF) |
| 79 | Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection? | 0.2 | 1 | Citations (PDF) |
| 80 | Humoral Response in Hemodialysis Patients Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review of Literature | 3.0 | 29 | Citations (PDF) |
| 81 | Update on the status of COVID-19 vaccination in Italy—April 2023 | 2.8 | 2 | Citations (PDF) |
| 82 | Practical recommendations for managing hemolyzed samples in clinical chemistry testing | 0.3 | 0 | Citations (PDF) |
| 83 | Addressing standardized definitions of post-COVID and long-COVID | 2.4 | 15 | Citations (PDF) |
| 84 | ¿Son los anticuerpos IgG e IgM contra los antígenos S y N del SARS-CoV-2 siempre predictores de infección previa por SARS-CoV-2? | 0.2 | 0 | Citations (PDF) |
| 85 | Effects of Different Types of Recombinant SARS-CoV-2 Spike Protein on Circulating Monocytes’ Structure | 4.5 | 1 | Citations (PDF) |
| 86 | Understanding the biological success of SARS-CoV-2: Immunoevasion strategies and beyond | 2.9 | 0 | Citations (PDF) |
| 87 | Long‐term stability of pleural fluid carcinoembryonic antigen and its effect on the diagnostic accuracy for malignant pleural effusion | 2.0 | 10 | Citations (PDF) |
| 88 | Characteristics of Phase IV Clinical Trials in Oncology: An Analysis Using the ClinicalTrials.gov Registry Data | 3.1 | 6 | Citations (PDF) |
| 89 | Safety monitoring of drug-induced muscle injury and rhabdomyolysis: a biomarker-guided approach for clinical practice and drug trials | 2.4 | 10 | Citations (PDF) |
| 90 | COVID-19 and smoking: Considerations after two years | 2.9 | 3 | Citations (PDF) |
| 91 | Results of the first survey of the EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) | 2.4 | 3 | Citations (PDF) |
| 92 | Incomplete filling of spray-dried K<sub>2</sub>EDTA evacuated blood tubes: impact on measuring routine hematological parameters on Sysmex XN-10 | 1.4 | 5 | Citations (PDF) |
| 93 | Can cellular and humoral immunity predict response to BNT162b2 bivalent booster? | 0.7 | 0 | Citations (PDF) |
| 94 | COVID-19: the global health emergency is over for the WHO, but not yet for laboratory medicine | 0.7 | 5 | Citations (PDF) |
| 95 | Red blood cell distribution width (RDW) is a significant predictor of survival in laryngeal cancer patients: Systematic literature review and meta-analysis | 1.9 | 9 | Citations (PDF) |
| 96 | Plasma Bile Acid Profiling and Modulation of Secreted Mucin 5AC in Cholangiocarcinoma | 4.5 | 3 | Citations (PDF) |
| 97 | SARS-CoV-2: An Update on the Biological Interplay with the Human HostCovid, 2023, 3, 1586-1600 | 1.0 | 3 | Citations (PDF) |
| 98 | Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2 | 0.2 | 0 | Citations (PDF) |
| 99 | Niveles séricos de antígeno prostático específico (PSA) tras vacunación primaria con BNT162b2 | 0.2 | 0 | Citations (PDF) |
| 100 | Urine dipstick for screening plasma glucose and bilirubin in low resource settings: a proof-of-concept study | 0.2 | 0 | Citations (PDF) |
| 101 | Humoral response is enhanced after ipsilateral double intramuscular injection of BNT162b2 COVID-19 vaccine | 0.7 | 0 | Citations (PDF) |
| 102 | Reporting SARS-CoV-2 viral load from upper respiratory tract specimens in the post-emergency phase: a narrative review | 0.2 | 0 | Citations (PDF) |
| 103 | COVID-19 testing in the post-emergency period | 0.2 | 0 | Citations (PDF) |
| 104 | Is mixing of blood gas syringes after collection really necessary? | 0.7 | 0 | Citations (PDF) |
| 105 | Uso de una tira reactiva paraorina en la evaluación de las concentraciones de glucosa y bilirrubina en plasma en entornos con recursos limitados: un estudio de prueba de concepto | 0.2 | 0 | Citations (PDF) |
| 106 | Cytokeratin 18 cell death assays as biomarkers for quantification of apoptosis and necrosis in COVID-19: a prospective, observational study | 2.0 | 13 | Citations (PDF) |
| 107 | Repeated Passive Mobilization to Stimulate Vascular Function in Individuals of Advanced Age Who Are Chronically Bedridden: A Randomized Controlled Trial | 3.5 | 7 | Citations (PDF) |
| 108 | The role of D-dimer in periprosthetic joint infection: a systematic review and meta-analysis | 1.4 | 14 | Citations (PDF) |
| 109 | Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature | 2.6 | 40 | Citations (PDF) |
| 110 | COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check? | 2.6 | 52 | Citations (PDF) |
| 111 | Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms? | 2.9 | 7 | Citations (PDF) |
| 112 | Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals | 1.4 | 6 | Citations (PDF) |
| 113 | Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis | 2.4 | 10 | Citations (PDF) |
| 114 | Is body temperature mass screening a reliable and safe option for preventing COVID-19 spread? | 1.4 | 13 | Citations (PDF) |
| 115 | Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More | 2.6 | 26 | Citations (PDF) |
| 116 | Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers | 1.9 | 23 | Citations (PDF) |
| 117 | Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT) | 2.4 | 31 | Citations (PDF) |
| 118 | Blood lactate concentration in COVID-19: a systematic literature review | 2.4 | 56 | Citations (PDF) |
| 119 | Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS | 2.5 | 28 | Citations (PDF) |
| 120 | COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections | 2.9 | 9 | Citations (PDF) |
| 121 | Neutralizing potency of COVID‐19 vaccines against the SARS‐CoV‐2 Omicron (B.1.1.529) variant | 3.8 | 26 | Citations (PDF) |
| 122 | Red Blood Cell Distribution Width in Hospitalized COVID-19 Patients | 2.6 | 18 | Citations (PDF) |
| 123 | Variación longitudinal comparativa de los anticuerpos totales, IgG e IgA contra el SARS-CoV-2 en receptores de la vacuna BNT162b2 | 0.2 | 0 | Citations (PDF) |
| 124 | The presence of anti–SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization | 2.2 | 3 | Citations (PDF) |
| 125 | Primary COVID-19 vaccine cycle and booster doses efficacy: analysis of Italian nationwide vaccination campaign | 0.3 | 44 | Citations (PDF) |
| 126 | Early prediction of COVID-19-associated acute kidney injury: Are serum NGAL and serum Cystatin C levels better than serum creatinine? | 1.9 | 29 | Citations (PDF) |
| 127 | Virucidal effects of mouthwashes or mouth rinses: a world of caution for molecular detection of SARS-CoV-2 in saliva | 1.4 | 5 | Citations (PDF) |
| 128 | Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay | 1.1 | 5 | Citations (PDF) |
| 129 | Association between KLF6 rs3750861 polymorphism and plasma ceramide concentrations in post-menopausal women with type 2 diabetes | 3.4 | 2 | Citations (PDF) |
| 130 | Prognostic value of growth differentiation factor 15 in COVID-19 | 1.3 | 2 | Citations (PDF) |
| 131 | Laboratory testing for platelet factor 4 antibodies: differential utility for diagnosis/exclusion of heparin induced thrombocytopenia versus suspected vaccine induced thrombotic thrombocytopenia | 1.6 | 19 | Citations (PDF) |
| 132 | Diagnostic performance of the fully automated Roche Elecsys SARS-CoV-2 antigen electrochemiluminescence immunoassay: a pooled analysis | 2.4 | 21 | Citations (PDF) |
| 133 | Post-Vaccination SARS-CoV-2 Infections among Health Workers at the University Hospital of Verona, Italy: A Retrospective Cohort Survey | 3.0 | 27 | Citations (PDF) |
| 134 | Commercial immunoassays for detection of anti-SARS-CoV-2 spike and RBD antibodies: urgent call for validation against new and highly mutated variants | 2.4 | 36 | Citations (PDF) |
| 135 | Updated picture of SARS-CoV-2 variants and mutations | 1.4 | 64 | Citations (PDF) |
| 136 | The many clinical advantages of reporting the cycle threshold (Ct) value | 1.8 | 5 | Citations (PDF) |
| 137 | The landscape of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic mutations | 0.7 | 1 | Citations (PDF) |
| 138 | SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load | 2.9 | 21 | Citations (PDF) |
| 139 | Analysis of online search trends suggests that SARS-CoV-2 Omicron (B.1.1.529) variant causes different symptoms | 2.9 | 30 | Citations (PDF) |
| 140 | Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review | 5.8 | 89 | Citations (PDF) |
| 141 | Preanalytical quality improvement – an interdisciplinary journey | 2.4 | 17 | Citations (PDF) |
| 142 | Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals | 2.4 | 17 | Citations (PDF) |
| 143 | Getting smart with coagulation | 3.9 | 5 | Citations (PDF) |
| 144 | Diagnostic accuracy of the ultrasensitive S-PLEX SARS-CoV-2 N electrochemiluminescence immunoassay | 2.4 | 9 | Citations (PDF) |
| 145 | Characterization of the significant decline in humoral immune response six months post‐SARS‐CoV‐2 mRNA vaccination: A systematic review | 3.8 | 126 | Citations (PDF) |
| 146 | Fujirebio Lumipulse SARS-CoV-2 antigen immunoassay: pooled analysis of diagnostic accuracy | 1.4 | 16 | Citations (PDF) |
| 147 | Is there a correlation between MOG‐associated disorder and SARS‐CoV‐2 infection? | 3.6 | 25 | Citations (PDF) |
| 148 | Serum C reactive protein predicts humoral response after BNT162b2 booster administration | 2.9 | 5 | Citations (PDF) |
| 149 | COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel? | 2.2 | 19 | Citations (PDF) |
| 150 | FebriDx for rapid screening of patients with suspected COVID-19 upon hospital admission: systematic literature review and meta-analysis | 2.5 | 10 | Citations (PDF) |
| 151 | Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination | 0.2 | 3 | Citations (PDF) |
| 152 | The Predictive Value of Serum ACE2 and TMPRSS2 Concentrations in Patients with COVID-19—A Prospective Pilot Study | 2.6 | 9 | Citations (PDF) |
| 153 | LumiraDX SARS-CoV-2 Antigen Test for Diagnosing Acute SARS-CoV-2 Infection: Critical Literature Review and Meta-Analysis | 3.0 | 7 | Citations (PDF) |
| 154 | Novel Translational Read-through–Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome | 3.5 | 15 | Citations (PDF) |
| 155 | Artificial intelligence at the time of COVID-19: who does the lion’s share? | 2.4 | 5 | Citations (PDF) |
| 156 | <i>Ad interim</i> recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group | 2.4 | 15 | Citations (PDF) |
| 157 | Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study | 2.6 | 9 | Citations (PDF) |
| 158 | Cell-Free DNA, Neutrophil extracellular traps (NETs), and Endothelial Injury in Coronavirus Disease 2019– (COVID-19–) Associated Acute Kidney Injury | 3.8 | 31 | Citations (PDF) |
| 159 | Three-month <i>ad interim</i> analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster | 2.4 | 2 | Citations (PDF) |
| 160 | Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers | 0.2 | 0 | Citations (PDF) |
| 161 | Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants | 10.4 | 44 | Citations (PDF) |
| 162 | Real-world effectiveness of COVID-19 vaccination among children in Italy | 2.2 | 4 | Citations (PDF) |
| 163 | Impacto de la vacunación primaria con BNT162b2 y una dosis de refuerzo homóloga en los anticuerpos IgA contra SARS-CoV-2 en profesionales sanitarios seronegativos | 0.2 | 0 | Citations (PDF) |
| 164 | Homocysteine in coronavirus disease (COVID-19): a systematic literature review | 1.4 | 28 | Citations (PDF) |
| 165 | Heparin: The Journey from Parenteral Agent to Nasal Delivery | 2.6 | 12 | Citations (PDF) |
| 166 | B-type Natriuretic Peptide May be Unsuitable for Diagnosing Central Acute Pulmonary Embolism | 0.1 | 0 | Citations (PDF) |
| 167 | Rethinking internal quality control: the time is now | 2.4 | 15 | Citations (PDF) |
| 168 | D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19 | 2.6 | 33 | Citations (PDF) |
| 169 | Clinical Chemistry and Laboratory Medicine: enjoying the present and assessing the future | 2.4 | 6 | Citations (PDF) |
| 170 | miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases | 4.0 | 11 | Citations (PDF) |
| 171 | Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes | 4.4 | 2 | Citations (PDF) |
| 172 | Estimating the worldwide burden of <scp>COVID</scp>‐19‐related anosmia and ageusia | 2.6 | 1 | Citations (PDF) |
| 173 | What is the impact of circulating histones in COVID-19: a systematic review | 2.4 | 13 | Citations (PDF) |
| 174 | SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large European Multicentric Cohort of Health Workers | 3.0 | 20 | Citations (PDF) |
| 175 | Evolution of throat symptoms during the COVID-19 pandemic in the US | 1.4 | 7 | Citations (PDF) |
| 176 | Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review | 8.5 | 426 | Citations (PDF) |
| 177 | Regional Association between Mean Air Temperature and Case Numbers of Multiple SARS-CoV-2 Lineages throughout the Pandemic | 3.3 | 12 | Citations (PDF) |
| 178 | Usefulness and Limitations of Anti-S IgG Assay in Detecting Previous SARS-CoV-2 Breakthrough Infection in Fully Vaccinated Healthcare Workers | 3.0 | 0 | Citations (PDF) |
| 179 | Could body temperature be used as surrogate measure of mRNA-based vaccination efficacy in the general population? | 0.7 | 0 | Citations (PDF) |
| 180 | D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review | 3.0 | 8 | Citations (PDF) |
| 181 | High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis | 3.0 | 4 | Citations (PDF) |
| 182 | Autoimmune Diseases Affecting Hemostasis: A Narrative Review | 4.5 | 15 | Citations (PDF) |
| 183 | The impact of COVID-19 on citations of laboratory medicine journals | 2.4 | 0 | Citations (PDF) |
| 184 | Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis | 2.6 | 177 | Citations (PDF) |
| 185 | Impact of COVID-19 pandemic on the worldwide burden of tinnitus | 1.7 | 4 | Citations (PDF) |
| 186 | Chronic Bedridden Condition Is Reflected by Substantial Changes in Plasma Inflammatory Profile | 4.4 | 3 | Citations (PDF) |
| 187 | Reliability of a single-nostril nasopharyngeal swab for diagnosing SARS-CoV-2 infection | 1.4 | 0 | Citations (PDF) |
| 188 | Evaluation of circ_100219 and miR-135b in serum and exosomes of healthy pregnant women | 1.8 | 7 | Citations (PDF) |
| 189 | ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID‐19: Evidence of SARS‐CoV‐2 induced secondary thrombotic microangiopathy | 1.3 | 61 | Citations (PDF) |
| 190 | Epidemiologic Burden of Red and Processed Meat Intake on Colorectal Cancer Mortality | 2.5 | 19 | Citations (PDF) |
| 191 | Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge | 6.8 | 1,145 | Citations (PDF) |
| 192 | Results of a hospital survey on critical values communication | 1.4 | 2 | Citations (PDF) |
| 193 | Impact of water temperature on reconstitution of quality controls for routine hemostasis testing | 1.4 | 1 | Citations (PDF) |
| 194 | Standardization and harmonization in hematology: Instrument alignment, quality control materials, and commutability issue | 1.3 | 12 | Citations (PDF) |
| 195 | Serum prealbumin values predict the severity of coronavirus disease 2019 (COVID‐19) | 3.8 | 9 | Citations (PDF) |
| 196 | Cardiac troponin elevation in patients with influenza virus infections | 3.9 | 16 | Citations (PDF) |
| 197 | A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib | 1.1 | 70 | Citations (PDF) |
| 198 | Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing | 1.9 | 11 | Citations (PDF) |
| 199 | Coronavirus Disease 2019–Associated Coagulopathy | 3.1 | 95 | Citations (PDF) |
| 200 | SARS‐CoV‐2 positive tests efficiently predict pressure on healthcare system | 3.8 | 3 | Citations (PDF) |
| 201 | Coronavirus disease 2019 is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1,7 | 3.8 | 35 | Citations (PDF) |
| 202 | Clinical value of anti‐SARS‐COV‐2 serum IgA titration in patients with COVID‐19 | 3.8 | 27 | Citations (PDF) |
| 203 | Anemia and COVID‐19: A prospective perspective | 3.8 | 23 | Citations (PDF) |
| 204 | Predicting mortality with cardiac troponins: recent insights from meta-analyses | 1.4 | 27 | Citations (PDF) |
| 205 | Machine learning in laboratory diagnostics: valuable resources or a big hoax? | 1.4 | 15 | Citations (PDF) |
| 206 | Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers | 1.9 | 22 | Citations (PDF) |
| 207 | Clinical assessment of the Roche SARS-CoV-2 rapid antigen test | 1.4 | 44 | Citations (PDF) |
| 208 | Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis | 2.6 | 41 | Citations (PDF) |
| 209 | Thrombin Generation in Patients with Coronavirus Disease 2019 | 2.6 | 15 | Citations (PDF) |
| 210 | Increased red blood cell distribution width in patients with plaque psoriasis | 1.9 | 10 | Citations (PDF) |
| 211 | Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study | 2.6 | 22 | Citations (PDF) |
| 212 | The role for pre-operative CT chest scans in suspected COVID-19 patients requiring emergent surgery | 0.5 | 0 | Citations (PDF) |
| 213 | Pooled analysis of monocyte distribution width in subjects with SARS‐CoV‐2 infection | 1.3 | 17 | Citations (PDF) |
| 214 | A robust machine learning framework to identify signatures for frailty: a nested case-control study in four aging European cohorts | 4.7 | 50 | Citations (PDF) |
| 215 | Is COVID-19 lockdown associated with vitamin D deficiency? | 0.3 | 15 | Citations (PDF) |
| 216 | Pseudothrombocytopenia—A Review on Causes, Occurrence and Clinical Implications | 2.6 | 58 | Citations (PDF) |
| 217 | Internet Searches for Over-the-Counter Analgesics During the COVID-19 Pandemic Outbreak in Italy | 2.1 | 3 | Citations (PDF) |
| 218 | Clinical Predictors of SARS-CoV-2 Testing Pressure on Clinical Laboratories: A Multinational Study Analyzing Google Trends and Over 100 Million Diagnostic Tests | 1.0 | 6 | Citations (PDF) |
| 219 | Complete Blood Count as point of care testing QBC STAR™: Preliminary evaluation | 1.3 | 1 | Citations (PDF) |
| 220 | Laparoscopic surgery during the COVID-19 pandemic: detection of SARS-COV-2 in abdominal tissues, fluids, and surgical smoke | 1.7 | 22 | Citations (PDF) |
| 221 | Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review | 2.1 | 42 | Citations (PDF) |
| 222 | Utility of Google Trends in anticipating Coronavirus Disease 2019 (COVID-19) outbreaks in Poland | 0.6 | 6 | Citations (PDF) |
| 223 | Incidence and predictive factors of acute diseases in patients with syncope: the ESCAPE study | 3.2 | 5 | Citations (PDF) |
| 224 | Mean Platelet Volume Predicts Severe COVID-19 Illness | 2.6 | 25 | Citations (PDF) |
| 225 | Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis | 2.6 | 106 | Citations (PDF) |
| 226 | Maximal aerobic capacity exercise testing protocols for elderly individuals in the era of COVID-19 | 2.9 | 1 | Citations (PDF) |
| 227 | COVID-19: which lessons have we learned? | 2.4 | 2 | Citations (PDF) |
| 228 | IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals | 2.4 | 37 | Citations (PDF) |
| 229 | Healthcare indicators associated with COVID-19 death rates in the European Union | 2.7 | 13 | Citations (PDF) |
| 230 | Are sniffer dogs a reliable approach for diagnosing SARS-CoV-2 infection? | 1.4 | 4 | Citations (PDF) |
| 231 | Potential drawbacks of pharmacy-based COVID-19 testing | 0.7 | 2 | Citations (PDF) |
| 232 | Potential drawbacks of SARS-CoV-2 seroprevalence surveys | 2.5 | 5 | Citations (PDF) |
| 233 | Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series | 2.4 | 51 | Citations (PDF) |
| 234 | How will emerging SARS-CoV-2 variants impact herd immunity? | 1.8 | 23 | Citations (PDF) |
| 235 | Complement levels at admission as a reflection of coronavirus disease 2019 (COVID‐19) severity state | 3.8 | 34 | Citations (PDF) |
| 236 | Comparison of forehead temperature screening with infra-red thermometer and thermal imaging scanner | 2.5 | 7 | Citations (PDF) |
| 237 | Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit | 0.2 | 2 | Citations (PDF) |
| 238 | Alterations in the lipid profile associate with a dysregulated inflammatory, prothrombotic, anti-fibrinolytic state and development of severe acute kidney injury in coronavirus disease 2019 (COVID-19): A study from Cincinnati, USA | 3.2 | 12 | Citations (PDF) |
| 239 | Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination | 3.0 | 81 | Citations (PDF) |
| 240 | Laboratory testing for <scp>ADAMTS13</scp>: Utility for <scp>TTP</scp> diagnosis/exclusion and beyond | 6.1 | 42 | Citations (PDF) |
| 241 | The complicated relationships of heparin‐induced thrombocytopenia and platelet factor 4 antibodies with COVID‐19 | 1.3 | 26 | Citations (PDF) |
| 242 | Evaluation of indoor hospital acclimatization of body temperature before COVID-19 fever screening | 2.5 | 6 | Citations (PDF) |
| 243 | Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study | 4.0 | 46 | Citations (PDF) |
| 244 | Evaluación de la prueba Fluorecare de anticuerpos contra la proteína Spike del SARS-CoV-2 en la práctica real | 0.2 | 0 | Citations (PDF) |
| 245 | Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients | 2.4 | 14 | Citations (PDF) |
| 246 | SARS-CoV-2 Infection in Health Workers: Analysis from Verona SIEROEPID Study during the Pre-Vaccination Era | 3.1 | 8 | Citations (PDF) |
| 247 | Defining laboratory medicine: a circle cannot be squared | 1.2 | 0 | Citations (PDF) |
| 248 | Performance of D-dimer for predicting sepsis mortality in the intensive care unit | 1.2 | 32 | Citations (PDF) |
| 249 | Adherence to the Standards for Reporting of Diagnostic Accuracy Studies (STARD): a survey of four journals in laboratory medicine | 1.8 | 14 | Citations (PDF) |
| 250 | Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay | 2.4 | 9 | Citations (PDF) |
| 251 | International Council for Standardisation in Haematology (ICSH) recommendations for collection of blood samples for coagulation testing | 1.3 | 39 | Citations (PDF) |
| 252 | Plasma Bile Acid Profile in Patients with and without Type 2 Diabetes | 3.5 | 51 | Citations (PDF) |
| 253 | Role of Inflammatory and Immune-Nutritional Prognostic Markers in Patients Undergoing Surgical Resection for Biliary Tract Cancers | 4.0 | 14 | Citations (PDF) |
| 254 | Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation | 4.8 | 23 | Citations (PDF) |
| 255 | Superspreaders, asymptomatics and COVID‐19 elimination | 1.8 | 0 | Citations (PDF) |
| 256 | Variation of Forehead Temperature during Routine Working Shift in Hospital Laboratory Personnel: Implications for SARS-CoV-2 Screening | 1.7 | 1 | Citations (PDF) |
| 257 | Prognostic value of troponin I in atrial fibrillation | 5.9 | 6 | Citations (PDF) |
| 258 | Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine–Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis | 10.4 | 105 | Citations (PDF) |
| 259 | Comparison of Freelite and N-Latex serum free light chain assays | 1.2 | 10 | Citations (PDF) |
| 260 | Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers | 2.9 | 33 | Citations (PDF) |
| 261 | Visceral obesity enhances inflammatory response after laparoscopic colorectal resection | 2.1 | 8 | Citations (PDF) |
| 262 | Antibody response induced by the boost overdose during COVID-19 heterologous prime-boost vaccination strategy | 1.6 | 7 | Citations (PDF) |
| 263 | International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing | 1.3 | 61 | Citations (PDF) |
| 264 | False-Positive Rates in Pediatric SARS-CoV-2 Serology Testing | 0.8 | 1 | Citations (PDF) |
| 265 | Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role? | 2.4 | 19 | Citations (PDF) |
| 266 | The strength of association between pre-and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay | 2.2 | 5 | Citations (PDF) |
| 267 | How to meet ISO15189:2012 pre-analytical requirements in clinical laboratories? A consensus document by the EFLM WG-PRE | 2.4 | 27 | Citations (PDF) |
| 268 | Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination | 2.4 | 24 | Citations (PDF) |
| 269 | Bladder urine oxygen partial pressure monitoring: Could it be a tool for early detection of acute kidney injury? | 0.5 | 6 | Citations (PDF) |
| 270 | Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA | 1.9 | 20 | Citations (PDF) |
| 271 | Periodontal Disease and Venous Thromboembolism | 2.6 | 4 | Citations (PDF) |
| 272 | Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness | 2.6 | 22 | Citations (PDF) |
| 273 | The Role of Epigenetics in the Regulation of Hemostatic Balance | 2.6 | 10 | Citations (PDF) |
| 274 | Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis | 1.4 | 50 | Citations (PDF) |
| 275 | The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19) | 2.4 | 44 | Citations (PDF) |
| 276 | Cytokine “storm”, cytokine “breeze”, or both in COVID-19? | 2.4 | 25 | Citations (PDF) |
| 277 | Clinicians’ and laboratory medicine specialists’ views on laboratory demand management: a survey in nine European countries | 1.4 | 11 | Citations (PDF) |
| 278 | Making sense of rapid antigen testing in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics | 1.4 | 45 | Citations (PDF) |
| 279 | Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis | 2.6 | 17 | Citations (PDF) |
| 280 | Unexpected volume of Google searches for COVID-19 symptoms in the prepandemic period in Lombardia, Italy | 1.5 | 1 | Citations (PDF) |
| 281 | The challenges of diagnosing diabetes in childhood | 1.4 | 4 | Citations (PDF) |
| 282 | Updated overview on the interplay between obesity and COVID-19 | 1.4 | 3 | Citations (PDF) |
| 283 | The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters | 2.4 | 20 | Citations (PDF) |
| 284 | IFCC Interim Guidelines on Biochemical/ Hematological Monitoring of COVID-19 Patients | 0.3 | 3 | Citations (PDF) |
| 285 | Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes | 3.6 | 14 | Citations (PDF) |
| 286 | Platelet Transfusion Thresholds: How Low Can We Go in Respect to Platelet Counting? | 2.6 | 23 | Citations (PDF) |
| 287 | Drug-Induced Thrombocytopenia: Mechanisms and Laboratory Diagnostics | 2.6 | 68 | Citations (PDF) |
| 288 | Worldwide asthma epidemiology: insights from the Global Health Data Exchange database | 2.8 | 112 | Citations (PDF) |
| 289 | Managing hemolyzed samples in clinical laboratories | 5.8 | 105 | Citations (PDF) |
| 290 | Kiwifruit and Cancer: An Overview of Biological Evidence | 2.5 | 18 | Citations (PDF) |
| 291 | Short-term stability of free metanephrines in plasma and whole blood | 2.4 | 10 | Citations (PDF) |
| 292 | Stability of refrigerated whole blood samples for osmotic fragility test | 0.1 | 6 | Citations (PDF) |
| 293 | Routine coagulation testing in Vacutainer® Citrate Plus tubes filled at minimum or optimal volume | 1.4 | 1 | Citations (PDF) |
| 294 | Updated overview on interplay between physical exercise, neurotrophins, and cognitive function in humans | 7.9 | 73 | Citations (PDF) |
| 295 | Worldwide burden of LDL cholesterol: Implications in cardiovascular disease | 3.4 | 52 | Citations (PDF) |
| 296 | International Council for Standardization in Haematology Recommendations for Hemostasis Critical Values, Tests, and Reporting | 2.6 | 23 | Citations (PDF) |
| 297 | Secondhand smoke and ischaemic heart disease: demographic characteristic of a worldwide healthcare problem | 2.1 | 2 | Citations (PDF) |
| 298 | An Update on Biological and Clinical Associations between E-Cigarettes and Myocardial Infarction | 2.6 | 8 | Citations (PDF) |
| 299 | Similar cardiovascular and autonomic responses in trained type 1 diabetes mellitus and healthy participants in response to half marathon | 6.2 | 8 | Citations (PDF) |
| 300 | Direct Oral Anticoagulants for Disseminated Intravascular Coagulation: An Alliterative Wordplay or Potentially Valuable Therapeutic Interventions? | 2.6 | 5 | Citations (PDF) |
| 301 | Particulate matter pollution and lung cancer: A worldwide perspective | 2.2 | 4 | Citations (PDF) |
| 302 | Worldwide epidemiology of carbon monoxide poisoning | 3.0 | 141 | Citations (PDF) |
| 303 | PREDICT: a checklist for preventing preanalytical diagnostic errors in clinical trials | 2.4 | 33 | Citations (PDF) |
| 304 | Prognostic Value of Troponins in Patients With or Without Coronary Heart Disease: Is it Dependent on Structure and Biology? | 1.0 | 11 | Citations (PDF) |
| 305 | A specific abnormal scattergram of peripheral blood leukocytes suggestive for the presence of proerythroblast | 1.3 | 1 | Citations (PDF) |
| 306 | Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes | 3.6 | 64 | Citations (PDF) |
| 307 | Cancer statistics: a comparison between World Health Organization (WHO) and Global Burden of Disease (GBD) | 0.3 | 167 | Citations (PDF) |
| 308 | SARS-CoV-2 antibodies titration: a reappraisal | 1.8 | 17 | Citations (PDF) |
| 309 | Repeated Testing in SARS-CoV-2 Infection | 3.1 | 1 | Citations (PDF) |
| 310 | Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia | 6.3 | 163 | Citations (PDF) |
| 311 | Diabetes mellitus association with coronavirus disease 2019 (<scp>COVID</scp>‐19) severity and mortality: A pooled analysis | 3.2 | 74 | Citations (PDF) |
| 312 | Updates on larynx cancer epidemiology | 4.3 | 205 | Citations (PDF) |
| 313 | Circulating Bile Acids Profiles in Obese Children and Adolescents: A Possible Role of Sex, Puberty and Liver Steatosis | 3.0 | 9 | Citations (PDF) |
| 314 | Machine Learning Model Comparison in the Screening of Cholangiocarcinoma Using Plasma Bile Acids Profiles | 3.0 | 14 | Citations (PDF) |
| 315 | A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19 | 2.4 | 62 | Citations (PDF) |
| 316 | Periodontitis, coronary heart disease and myocardial infarction: treat one, benefit all | 1.0 | 33 | Citations (PDF) |
| 317 | Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19) | 2.6 | 25 | Citations (PDF) |
| 318 | Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19) | 2.6 | 48 | Citations (PDF) |
| 319 | Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory | 2.1 | 56 | Citations (PDF) |
| 320 | Nonequivalence of erythrocyte sedimentation rate assessed in whole blood anticoagulated with K2EDTA or sodium citrate | 0.7 | 0 | Citations (PDF) |
| 321 | Safety procedures for exercise testing in the scenario of COVID-19: a position statement of the Società Italiana Scienze Motorie e Sportive | 1.1 | 14 | Citations (PDF) |
| 322 | Red Blood Cell Distribution Width (RDW) Predicts COVID-19 Severity: A Prospective, Observational Study from the Cincinnati SARS-CoV-2 Emergency Department Cohort | 3.0 | 74 | Citations (PDF) |
| 323 | Staff rostering, split team arrangement, social distancing (physical distancing) and use of personal protective equipment to minimize risk of workplace transmission during the COVID-19 pandemic: A simulation study | 1.9 | 26 | Citations (PDF) |
| 324 | A holistic approach for the diagnosis of venous thromboembolism | 0.7 | 0 | Citations (PDF) |
| 325 | Potential drawbacks of frequent asymptomatic coronavirus disease 2019 (COVID-19) testing | 2.1 | 11 | Citations (PDF) |
| 326 | Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort | 2.1 | 90 | Citations (PDF) |
| 327 | Do Antioxidant Vitamins Prevent Exercise-Induced Muscle Damage? A Systematic Review | 5.9 | 24 | Citations (PDF) |
| 328 | Analysis of clinical and demographic heterogeneity of patients dying from COVID-19 in Brazil versus China and Italy | 0.2 | 8 | Citations (PDF) |
| 329 | Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis | 4.5 | 29 | Citations (PDF) |
| 330 | Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review | 1.9 | 136 | Citations (PDF) |
| 331 | Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research | 4.2 | 232 | Citations (PDF) |
| 332 | Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer | 2.0 | 47 | Citations (PDF) |
| 333 | Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis | 1.7 | 476 | Citations (PDF) |
| 334 | The need for accurate D‐dimer reporting in COVID‐19: Communication from the ISTH SSC on fibrinolysis | 3.9 | 56 | Citations (PDF) |
| 335 | The global burden of pancreatic cancer | 1.2 | 119 | Citations (PDF) |
| 336 | Laboratory abnormalities in children with novel coronavirus disease 2019 | 2.4 | 205 | Citations (PDF) |
| 337 | Combining old and new strategies for colorectal cancer screening | 1.8 | 4 | Citations (PDF) |
| 338 | Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) | 2.9 | 340 | Citations (PDF) |
| 339 | Interference from immunocomplexes on a high-sensitivity cardiac troponin T immunoassay | 2.4 | 2 | Citations (PDF) |
| 340 | Laboratory abnormalities in patients with COVID-2019 infection | 2.4 | 800 | Citations (PDF) |
| 341 | The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks | 2.4 | 313 | Citations (PDF) |
| 342 | D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis | 4.2 | 514 | Citations (PDF) |
| 343 | Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis | 1.6 | 1,455 | Citations (PDF) |
| 344 | Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) | 2.4 | 525 | Citations (PDF) |
| 345 | GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease | 4.5 | 13 | Citations (PDF) |
| 346 | In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers | 3.1 | 3 | Citations (PDF) |
| 347 | Bile Acids Quantification by Liquid Chromatography–Tandem Mass Spectrometry: Method Validation, Reference Range, and Interference Study | 3.0 | 20 | Citations (PDF) |
| 348 | COVID-19: unravelling the clinical progression of nature’s virtually perfect biological weapon | 1.8 | 107 | Citations (PDF) |
| 349 | An Estimation of the Worldwide Epidemiologic Burden of Physical Inactivity-Related Ischemic Heart Disease | 2.1 | 45 | Citations (PDF) |
| 350 | The worldwide burden of smoking‐related oral cancer deaths | 2.4 | 26 | Citations (PDF) |
| 351 | Inappropriate use of laboratory tests: How availability triggers demand – Examples across Europe | 1.6 | 29 | Citations (PDF) |
| 352 | Which lessons shall we learn from the 2019 novel coronavirus outbreak? | 1.8 | 116 | Citations (PDF) |
| 353 | Analytical Evaluation of the New Beckman Coulter Access Procalcitonin (PCT) Chemiluminescent Immunoassay | 3.0 | 8 | Citations (PDF) |
| 354 | Gender-based fatal effects of ambient air pollution | 4.4 | 4 | Citations (PDF) |
| 355 | Further advices on measuring lipoprotein(a) for reducing the residual cardiovascular risk on statin therapy | 2.4 | 2 | Citations (PDF) |
| 356 | Diagnostic and prognostic value of red blood cell distribution width in sepsis: A narrative review | 1.9 | 95 | Citations (PDF) |
| 357 | Emergency diagnostic testing in pregnancy | 0.7 | 2 | Citations (PDF) |
| 358 | The novel coronavirus (2019-nCoV) outbreak: think the unthinkable and be prepared to face the challenge | 1.4 | 55 | Citations (PDF) |
| 359 | Active smoking and COVID-19: a double-edged sword | 2.9 | 33 | Citations (PDF) |
| 360 | Clinical and demographic characteristics of patients dying from COVID‐19 in Italy vs China | 3.8 | 108 | Citations (PDF) |
| 361 | The Vascular Side of Chronic Bed Rest: When a Therapeutic Approach Becomes Deleterious | 2.6 | 18 | Citations (PDF) |
| 362 | Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis | 3.2 | 164 | Citations (PDF) |
| 363 | Antisense lipoprotein[a] therapy: State-of-the-art and future perspectives | 2.9 | 12 | Citations (PDF) |
| 364 | Eosinophil count in severe coronavirus disease 2019 | 0.5 | 43 | Citations (PDF) |
| 365 | Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm | 1.8 | 163 | Citations (PDF) |
| 366 | COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up | 2.4 | 2,612 | Citations (PDF) |
| 367 | Special Article - Exercise-induced right ventricular injury or arrhythmogenic cardiomyopathy (ACM): The bright side and the dark side of the moon | 5.9 | 28 | Citations (PDF) |
| 368 | Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature | 6.8 | 238 | Citations (PDF) |
| 369 | Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19) | 2.1 | 285 | Citations (PDF) |
| 370 | Gene therapy for hemophilias: the end of phenotypic testing or the start of a new era? | 1.0 | 5 | Citations (PDF) |
| 371 | Integrated diagnostics | 1.2 | 49 | Citations (PDF) |
| 372 | Errors within the total laboratory testing process, from test selection to medical decision-making – A review of causes, consequences, surveillance and solutions | 1.2 | 69 | Citations (PDF) |
| 373 | Laboratory medicine resilience during coronavirus disease 2019 (COVID-19) pandemic | 0.2 | 10 | Citations (PDF) |
| 374 | Brief update on coronavirus disease 2019 (COVID-19) diagnostics | 0.2 | 5 | Citations (PDF) |
| 375 | Mass spectrometry and total laboratory automation: opportunities and drawbacks | 2.4 | 20 | Citations (PDF) |
| 376 | The “olfactory fingerprint”: can diagnostics be improved by combining canine and digital noses? | 2.4 | 24 | Citations (PDF) |
| 377 | Effects of endurance exercise on serum concentration of calcitonin gene-related peptide (CGRP): a potential link between exercise intensity and headache | 2.4 | 17 | Citations (PDF) |
| 378 | A modern and pragmatic definition of Laboratory Medicine | 2.4 | 45 | Citations (PDF) |
| 379 | Exact time of venous blood sample collection – an unresolved issue, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE) | 2.4 | 11 | Citations (PDF) |
| 380 | Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis | 2.4 | 1,613 | Citations (PDF) |
| 381 | Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy | 2.4 | 95 | Citations (PDF) |
| 382 | Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays | 2.4 | 111 | Citations (PDF) |
| 383 | Urinalysis parameters for predicting severity in coronavirus disease 2019 (COVID-19) | 2.4 | 19 | Citations (PDF) |
| 384 | Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey | 2.4 | 23 | Citations (PDF) |
| 385 | Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey | 2.4 | 23 | Citations (PDF) |
| 386 | Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence | 2.4 | 170 | Citations (PDF) |
| 387 | Do genetic polymorphisms in angiotensin converting enzyme 2 (<i>ACE2</i>) gene play a role in coronavirus disease 2019 (COVID-19)? | 2.4 | 63 | Citations (PDF) |
| 388 | Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital | 2.4 | 29 | Citations (PDF) |
| 389 | Preliminary evaluation of Roche Cobas Elecsys Anti-SARS-CoV-2 chemiluminescence immunoassay | 2.4 | 15 | Citations (PDF) |
| 390 | Validation of the Corona-Score for rapid identification of SARS-CoV-2 infections in patients seeking emergency department care in the United States | 2.4 | 26 | Citations (PDF) |
| 391 | SARS-CoV-2 serosurvey in health care workers of the Veneto Region | 2.4 | 68 | Citations (PDF) |
| 392 | IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection | 2.4 | 48 | Citations (PDF) |
| 393 | IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2 | 2.4 | 63 | Citations (PDF) |
| 394 | IFCC Interim Guidelines on Biochemical/Hematological Monitoring of COVID-19 Patients | 2.4 | 47 | Citations (PDF) |
| 395 | Editorial and Executive Summary: IFCC Interim Guidelines on Clinical Laboratory testing during the COVID-19 Pandemic | 2.4 | 27 | Citations (PDF) |
| 396 | Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19) | 1.4 | 285 | Citations (PDF) |
| 397 | Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States | 1.4 | 338 | Citations (PDF) |
| 398 | Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19) | 1.4 | 10 | Citations (PDF) |
| 399 | Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males? | 1.4 | 10 | Citations (PDF) |
| 400 | Asymptomatic COVID-19 transmission: the importance of avoiding official miscommunication | 1.4 | 9 | Citations (PDF) |
| 401 | False negative RT-PCR or false positive serological testing in SARS-CoV-2 diagnostics? Navigating between Scylla and Charybdis to prevent misclassification bias in COVID-19 clinical investigations | 1.4 | 11 | Citations (PDF) |
| 402 | Mean platelet volume in arterial and venous thrombotic disorders | 1.2 | 11 | Citations (PDF) |
| 403 | Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis | 0.6 | 314 | Citations (PDF) |
| 404 | Do “Disease Awareness Days” Work? A 5-Year Investigation Using Google Trends | 2.7 | 6 | Citations (PDF) |
| 405 | Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19) | 1.1 | 45 | Citations (PDF) |
| 406 | Laboratory medicine resilience during coronavirus disease 2019 (Covid-19) pandemic | 0.2 | 10 | Citations (PDF) |
| 407 | La capacidad de resiliencia de la medicina de laboratorio durante la pandemia de la enfermedad por coronavirus (COVID-19) iniciada en 2019 | 0.2 | 0 | Citations (PDF) |
| 408 | Diagnostic and clinical significance of “atypical” symptoms in coronavirus disease 2019 | 0.6 | 24 | Citations (PDF) |
| 409 | Exploring the association between extra-cardiac troponin elevations and risk of future mortality | 1.9 | 2 | Citations (PDF) |
| 410 | Relationship between Anthropometric Characteristics and Success in Different Cycling Terrains | 1.7 | 2 | Citations (PDF) |
| 411 | B vitamin blood concentrations and one-carbon metabolism polymorphisms in a sample of Italian women and men attending a unit of transfusion medicine: a cross-sectional study | 3.5 | 6 | Citations (PDF) |
| 412 | Cardiac troponin I and T: Exploring popularity with Google Trends | 1.3 | 0 | Citations (PDF) |
| 413 | Preanalytical challenges — time for solutions (In Russ.) | 0.3 | 1 | Citations (PDF) |
| 414 | Molecular diagnostics at the times of SARS-CoV-2 outbreak | 1.4 | 3 | Citations (PDF) |
| 415 | Breve actualización sobre el diagnóstico de la enfermedad por coronavirus 2019 (COVID-19) | 0.2 | 0 | Citations (PDF) |
| 416 | Upper respiratory samples pooling for screening SARS-CoV-2 infection: ready for the prime time? | 2.4 | 1 | Citations (PDF) |
| 417 | Blood sample quality | 1.4 | 111 | Citations (PDF) |
| 418 | Myocardial Infarction, Unstable Angina, and White Thrombi: Time to Move Forward? | 2.6 | 1 | Citations (PDF) |
| 419 | Managing inappropriate utilization of laboratory resources | 1.4 | 58 | Citations (PDF) |
| 420 | The Model List of Essential In Vitro Diagnostics: nuisance or opportunity? | 1.4 | 4 | Citations (PDF) |
| 421 | Heparin and citrate additive carryover during blood collection | 2.4 | 6 | Citations (PDF) |
| 422 | Are icteric and lipemic indices reliable to screen for hyperbilirubinemia and hypertriglyceridemia? | 2.4 | 8 | Citations (PDF) |
| 423 | CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia patients | 1.5 | 4 | Citations (PDF) |
| 424 | Undetected coronary artery disease in apparently healthy athletes | 2.1 | 5 | Citations (PDF) |
| 425 | Current and Emerging Direct Oral Anticoagulants: State-of-the-Art | 2.6 | 53 | Citations (PDF) |
| 426 | Understanding cardiac troponin biology: all other cardiac biomarkers shall rest in peace? | 0.7 | 7 | Citations (PDF) |
| 427 | Measurement of High-Sensitivity Cardiac Troponin in Pulmonary Embolism: Useful Test or a Clinical Distraction | 2.6 | 15 | Citations (PDF) |
| 428 | Increased Gene Expression of RUNX2 and SOX9 in Mesenchymal Circulating Progenitors Is Associated with Autophagy during Physical Activity | 4.6 | 32 | Citations (PDF) |
| 429 | Can presepsin be used for screening invasive fungal infections? | 1.8 | 15 | Citations (PDF) |
| 430 | Secondhand smoke in childhood: The world‐wide burden of a major public health‐care problem | 0.9 | 1 | Citations (PDF) |
| 431 | Worldwide epidemiology of alcohol and drugs abuse | 2.9 | 11 | Citations (PDF) |
| 432 | Neuromuscular Electrical Stimulation: A New Therapeutic Option for Chronic Diseases Based on Contraction-Induced Myokine Secretion | 2.9 | 35 | Citations (PDF) |
| 433 | La liaison fructueuse: Laboratory and emergency medicine | 0.2 | 2 | Citations (PDF) |
| 434 | Time-dependent results in troponin exercise-induced fluctuations | 2.3 | 0 | Citations (PDF) |
| 435 | European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EF | 1.2 | 45 | Citations (PDF) |
| 436 | Cardiometabolic non-response to aerobic exercise: Identifying subclinical ischaemic coronary disease | 2.1 | 2 | Citations (PDF) |
| 437 | Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays | 2.4 | 31 | Citations (PDF) |
| 438 | Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta‐Analysis | 10.6 | 42 | Citations (PDF) |
| 439 | Exertional hematuria: definition, epidemiology, diagnostic and clinical considerations | 2.4 | 6 | Citations (PDF) |
| 440 | Identification and management of spurious hemolysis: controversies, concerns and criticisms | 2.4 | 4 | Citations (PDF) |
| 441 | Preanalytical challenges – time for solutions | 2.4 | 61 | Citations (PDF) |
| 442 | Clinical usefulness of automated cellular analysis of synovial fluids: a paradigmatic case report for diagnosing peri-prosthetic infections | 0.3 | 0 | Citations (PDF) |
| 443 | Can citrate plasma be used in exceptional circumstances for some clinical chemistry and immunochemistry tests? | 1.4 | 3 | Citations (PDF) |
| 444 | Association between non-alcoholic fatty liver disease and decreased lung function in adults: A systematic review and meta-analysis | 3.6 | 34 | Citations (PDF) |
| 445 | Advantages and limitations of total laboratory automation: a personal overview | 2.4 | 126 | Citations (PDF) |
| 446 | Professor Howard A. Morris | 2.4 | 0 | Citations (PDF) |
| 447 | Statins popularity: A global picture | 2.7 | 24 | Citations (PDF) |
| 448 | Is one cardiac troponin better than the other? | 0.7 | 6 | Citations (PDF) |
| 449 | Vascular Disease and Dementia: Lipoprotein(a) as a Neglected Link | 2.6 | 7 | Citations (PDF) |
| 450 | A paradigmatic case of haemolysis and pseudohyperkalemia in blood gas analysis | 1.2 | 4 | Citations (PDF) |
| 451 | Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease | 5.5 | 19 | Citations (PDF) |
| 452 | Is anticoagulant therapy always indicated in “medium-risk” patients with first diagnosed atrial fibrillation? Insights from a real world, 10-year observational study | 2.3 | 0 | Citations (PDF) |
| 453 | Comparison between optical microscopy and automation for cytometric analysis of pericardial fluids in a cohort of adult subjects undergoing cardiac surgery | 2.0 | 6 | Citations (PDF) |
| 454 | Impact of low volume citrate tubes on results of first‐line hemostasis testing | 1.3 | 4 | Citations (PDF) |
| 455 | Albumin-Adjusted Calcium and Ionized Calcium for Assessing Calcium Status in Hospitalized Patients | 1.1 | 11 | Citations (PDF) |
| 456 | Recent Advances in Mainstream Hemostasis Diagnostics and Coagulation Testing | 2.6 | 19 | Citations (PDF) |
| 457 | Influence of hypertriglyceridemia, hyperbilirubinemia and hemolysis on thrombin generation in human plasma | 2.4 | 13 | Citations (PDF) |
| 458 | Cost, profitability and value of laboratory diagnostics: in God we trust, all others bring data | 1.2 | 18 | Citations (PDF) |
| 459 | Analytical Assessment of the New Roche Cobas t 711 Fully Automated Coagulation Analyzer | 2.6 | 19 | Citations (PDF) |
| 460 | Sepsis biomarkers: past, present and future | 2.4 | 57 | Citations (PDF) |
| 461 | Public perception of diagnostic and laboratory errors among Internet users | 1.4 | 2 | Citations (PDF) |
| 462 | Emergency department management of patients with syncope according to the 2018 ESC guidelines: Main innovations and aspect deserving a further improvement | 2.3 | 5 | Citations (PDF) |
| 463 | Effects of Flywheel Strength Training on the Running Economy of Recreational Endurance Runners | 2.2 | 15 | Citations (PDF) |
| 464 | Lack of harmonization in high fluorescent cell automated counts with body fluids mode in ascitic, pleural, synovial, and cerebrospinal fluids | 1.3 | 13 | Citations (PDF) |
| 465 | Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease | 3.6 | 41 | Citations (PDF) |
| 466 | Current Cancer Epidemiology | 2.7 | 1,251 | Citations (PDF) |
| 467 | Popularity of sleep disordered breathing in childhood: an analysis of worldwide search using Google Trends | 1.4 | 5 | Citations (PDF) |
| 468 | European survey on preanalytical sample handling – Part 1: How do European laboratories monitor the preanalytical phase? On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Pha | 1.2 | 25 | Citations (PDF) |
| 469 | Blood sample quality using Greiner Bio-One HOLDEX® Single-Use Holder and VACUETTE® SAFELINK holder with male luer lock: a comparative study | 0.7 | 0 | Citations (PDF) |
| 470 | Pneumatic tube system transport and false hyperkalemia related to leukocytosis: a retrospective analysis | 0.1 | 4 | Citations (PDF) |
| 471 | Routine cardiac troponin assessment after percutaneous coronary intervention: useful or hype? | 1.2 | 6 | Citations (PDF) |
| 472 | Joint EFLM-COLABIOCLI recommendation for venous blood sampling | 0.1 | 9 | Citations (PDF) |
| 473 | Physical activity and laryngeal cancer | 1.8 | 7 | Citations (PDF) |
| 474 | Analytical performance of the new D‐dimer and antithrombin assay on Roche cobas t 711 analyzer | 1.3 | 5 | Citations (PDF) |
| 475 | Systematic review with meta‐analysis: non‐alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density | 3.9 | 52 | Citations (PDF) |
| 476 | Willingness-to-pay threshold for preventing spurious hemolysis during blood sample collection | 1.4 | 2 | Citations (PDF) |
| 477 | The preanalytical phase in the era of high-throughput genetic testing. What the future holds | 1.4 | 4 | Citations (PDF) |
| 478 | How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors | 2.6 | 80 | Citations (PDF) |
| 479 | Understanding the “philosophy” of laboratory hemostasis | 1.4 | 13 | Citations (PDF) |
| 480 | Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes | 3.6 | 59 | Citations (PDF) |
| 481 | Harms and Benefits of Using Aspirin for Primary Prevention of Cardiovascular Disease: A Narrative Overview | 2.6 | 15 | Citations (PDF) |
| 482 | Values and stability of serum (or plasma) indices in uncentrifuged serum and lithium-heparin plasma | 1.4 | 4 | Citations (PDF) |
| 483 | Diabetes alert dogs: a narrative critical overview | 2.4 | 16 | Citations (PDF) |
| 484 | Assessment of Plasma Sample Quality on Siemens Atellica COAG 360 System | 2.6 | 5 | Citations (PDF) |
| 485 | Worldwide disease epidemiology in the older persons | 2.6 | 53 | Citations (PDF) |
| 486 | Multicenter observational study on the reliability of the HEART score | 1.6 | 14 | Citations (PDF) |
| 487 | Childhood nasal obstruction and sleep-disordered breathing during clinical setting: Myth or reality? | 0.2 | 1 | Citations (PDF) |
| 488 | Epidemiological, biological and clinical update on exercise-induced hemolysis | 1.8 | 72 | Citations (PDF) |
| 489 | Concise update on colorectal cancer epidemiology | 1.8 | 264 | Citations (PDF) |
| 490 | Are we overrating the extra-skeletal benefits of oral vitamin D supplementation? | 1.8 | 2 | Citations (PDF) |
| 491 | Circulating molecular biomarkers for screening or early diagnosis of colorectal cancer: which is ready for prime time? | 1.8 | 42 | Citations (PDF) |
| 492 | The role of red blood cell distribution width (RDW) in cardiovascular risk assessment: useful or hype? | 1.8 | 107 | Citations (PDF) |
| 493 | Pay less and spend more—the real value in healthcare procurement | 1.8 | 21 | Citations (PDF) |
| 494 | Evaluation of neutrophil-lymphocyte and platelet-lymphocyte ratios as predictors of 30-day mortality in patients hospitalized for an episode of acute decompensated heart failure | 1.9 | 37 | Citations (PDF) |
| 495 | Red blood cell distribution width predicts 1-month complications after percutaneous transluminal angioplasty | 1.9 | 3 | Citations (PDF) |
| 496 | Leukocytosis interference in clinical chemistry: shall we still interpret test results without hematological data? | 1.9 | 6 | Citations (PDF) |
| 497 | Project management in laboratory medicine | 1.9 | 19 | Citations (PDF) |
| 498 | Is Digital Epidemiology the Future of Clinical Epidemiology? | 2.7 | 19 | Citations (PDF) |
| 499 | Red blood cell distribution width: A marker of anisocytosis potentially associated with atrial fibrillation | 2.4 | 14 | Citations (PDF) |
| 500 | Validity and reliability of serologic immunophenotyping of multiple blood group systems by ORTHO Sera with fully automated procedure | 0.0 | 0 | Citations (PDF) |
| 501 | Is digital epidemiology reliable?—insight from updated cancer statistics | 1.8 | 15 | Citations (PDF) |
| 502 | Thrombin generation in different commercial sodium citrate blood tubes | 1.9 | 1 | Citations (PDF) |
| 503 | Increased red blood cell distribution width and platelet‑to‑lymphocyte ratio for predicting all‑cause mortality in patients with type 2 diabetes and advanced heart failure: a causal association or epiphenomenon? | 0.6 | 3 | Citations (PDF) |
| 504 | A brilliant dawn and an even brighter future for Annals of Translational Medicine | 1.8 | 0 | Citations (PDF) |
| 505 | Wspólne zalecenia EFLM-COLABIOCLI
dotyczące pobierania krwi żylnej | 0.2 | 1 | Citations (PDF) |
| 506 | Red Blood Cell Distribution Width Improves Reclassification of Patients Admitted to the Emergency Department with Acute Decompensated Heart Failure | 1.9 | 8 | Citations (PDF) |
| 507 | Local quality assurance of serum or plasma (HIL) indices | 1.9 | 26 | Citations (PDF) |
| 508 | Laboratory hemostasis: from biology to the bench | 2.4 | 44 | Citations (PDF) |
| 509 | Epigenetica e cancro del colon-retto: limiti e prospettive | 0.5 | 1 | Citations (PDF) |
| 510 | Preanalytical errors before and after implementation of an automatic blood tube labeling system in two outpatient phlebotomy centers | 2.4 | 1 | Citations (PDF) |
| 511 | PLCB3 Loss of Function Reduces <i>Pseudomonas aeruginosa</i>–Dependent IL-8 Release in Cystic Fibrosis | 4.3 | 16 | Citations (PDF) |
| 512 | A STARD-compliant prediction model for diagnosing thrombotic microangiopathies | 1.6 | 1 | Citations (PDF) |
| 513 | Are laboratory tests always needed? Frequency and causes of laboratory overuse in a hospital setting | 1.9 | 59 | Citations (PDF) |
| 514 | Practical recommendations for managing hemolyzed samples in clinical chemistry testing | 2.4 | 123 | Citations (PDF) |
| 515 | Harmonization of interpretative comments in laboratory hematology reporting: the recommendations of the Working Group on Diagnostic Hematology of the Italian Society of Clinical Chemistry and Clinical Molecular Biology (WGDH-SIBioC) | 2.4 | 11 | Citations (PDF) |
| 516 | Short- and medium-term biological variation estimates of red blood cell and reticulocyte parameters in healthy subjects | 2.4 | 16 | Citations (PDF) |
| 517 | Syncope: current knowledge, uncertainties and strategies for management optimisation in the emergency department | 1.4 | 4 | Citations (PDF) |
| 518 | PAFIYAMA syndrome evidence in highly trained population | 2.3 | 2 | Citations (PDF) |
| 519 | Preanalytical issues that may cause misdiagnosis in haemophilia and von Willebrand disease | 2.0 | 25 | Citations (PDF) |
| 520 | Scientific publishing in the “predatory” era | 2.4 | 8 | Citations (PDF) |
| 521 | Influence of middle-distance running on muscular micro RNAs | 1.3 | 17 | Citations (PDF) |
| 522 | Sphingolipids role in the regulation of inflammatory response: From leukocyte biology to bacterial infection | 3.0 | 34 | Citations (PDF) |
| 523 | Recent initiatives in harmonization of hemostasis practice | 2.4 | 13 | Citations (PDF) |
| 524 | Harmonization of laboratory hematology: a long and winding journey | 2.4 | 19 | Citations (PDF) |
| 525 | Procalcitonin for diagnosing and monitoring bacterial infections: for or against? | 2.4 | 27 | Citations (PDF) |
| 526 | The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke | 6.8 | 33 | Citations (PDF) |
| 527 | Validation of an immunoturbidimetric assay for assessment of C reactive protein in synovial fluid | 1.5 | 2 | Citations (PDF) |
| 528 | An Eighteen-Minute Submaximal Exercise Test to Assess Cardiac Fitness in Response to Aerobic Training | 2.2 | 1 | Citations (PDF) |
| 529 | Laboratory testing in the emergency department: an Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) and Academy of Emergency Medicine and Care (AcEMC) consensus report | 2.4 | 17 | Citations (PDF) |
| 530 | The clinical significance of <scp>DJ</scp>‐1 and <scp>HE</scp>4 in patients with endometrial cancer | 2.8 | 24 | Citations (PDF) |
| 531 | The EFLM strategy for harmonization of the preanalytical phase | 2.4 | 61 | Citations (PDF) |
| 532 | The risk of unjustified BRCA testing after the “Angelina Jolie effect”: how can we save (laboratory) medicine from the Internet? | 2.4 | 5 | Citations (PDF) |
| 533 | Visual assessment of sample quality: <i>quo usque tandem</i>? | 2.4 | 27 | Citations (PDF) |
| 534 | Red blood cell distribution width independently predicts 1-month mortality in acute decompensation of cirrhotic patients admitted to emergency department | 1.4 | 17 | Citations (PDF) |
| 535 | Challenges and Opportunities in Implementing Total Laboratory Automation | 1.1 | 64 | Citations (PDF) |
| 536 | Venous and Arterial Thromboses: Two Sides of the Same Coin? | 2.6 | 83 | Citations (PDF) |
| 537 | Innovative haematological parameters for early diagnosis of sepsis in adult patients admitted in intensive care unit | 2.0 | 18 | Citations (PDF) |
| 538 | Epidemiology and clinics of mushroom poisoning in Northern Italy: A 21-year retrospective analysis | 3.0 | 59 | Citations (PDF) |
| 539 | Recent developments and innovations in red blood cells diagnostics | 0.7 | 7 | Citations (PDF) |
| 540 | Hemostasis practice: state-of-the-art | 0.7 | 10 | Citations (PDF) |
| 541 | Glioblastoma biomarkers: finding a needle in a haystack | 0.7 | 3 | Citations (PDF) |
| 542 | Middle-distance running and DNA damage in diabetics | 0.7 | 2 | Citations (PDF) |
| 543 | Trends of popularity of cardiac biomarkers: Insights from Google Trends | 0.2 | 2 | Citations (PDF) |
| 544 | Evaluation of body fluid mode of Sysmex XN-9000 for white blood cell counts in cerebrospinal fluid | 0.7 | 2 | Citations (PDF) |
| 545 | Paroxysmal atrial fibrillation in young and middle-aged athletes (PAFIYAMA) syndrome in the real world: a paradigmatic case report | 1.8 | 5 | Citations (PDF) |
| 546 | Nutritional habits and bladder cancer | 1.3 | 4 | Citations (PDF) |
| 547 | Are we getting better at the preanalytical phase or just better at measuring it? | 0.7 | 11 | Citations (PDF) |
| 548 | Trauma-induced coagulopathy. A narrative review of goal-directed hemostatic resuscitation | 0.2 | 0 | Citations (PDF) |
| 549 | Dark chocolate modulates platelet function with a mechanism mediated by flavan-3-ol metabolites | 1.3 | 26 | Citations (PDF) |
| 550 | Diagnosing myocardial injury in the high-sensitivity troponin era | 0.2 | 1 | Citations (PDF) |
| 551 | Physical exercise and migraine: for or against? | 1.8 | 33 | Citations (PDF) |
| 552 | “Ultra-sensitive” cardiac troponins: Requirements for effective implementation in clinical practice | 1.2 | 21 | Citations (PDF) |
| 553 | A Six-Sigma approach for comparing diagnostic errors in healthcare—where does laboratory medicine stand? | 1.8 | 34 | Citations (PDF) |
| 554 | Biochemical markers of acute intestinal ischemia: possibilities and limitations | 1.8 | 87 | Citations (PDF) |
| 555 | e-thrombosis: epidemiology, physiopathology and rationale for preventing computer-related thrombosis | 1.8 | 13 | Citations (PDF) |
| 556 | Sympatho-adrenergic activation by endurance exercise: Effect on metanephrines spillover and its role in predicting athlete’s performance | 1.7 | 14 | Citations (PDF) |
| 557 | The state-of-the-art of “high-sensitivity” immunoassay for measuring cardiac troponin I and T | 0.7 | 9 | Citations (PDF) |
| 558 | Jillian Russyll (AKA Jill) Tate | 2.4 | 0 | Citations (PDF) |
| 559 | D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications | 5.8 | 178 | Citations (PDF) |
| 560 | Rare thrombophilic conditions | 1.8 | 15 | Citations (PDF) |
| 561 | Red blood cell distribution width predicts long-term outcomes in sepsis patients admitted to the intensive care unit | 1.6 | 48 | Citations (PDF) |
| 562 | How do I peer-review a scientific article?—a personal perspective | 1.8 | 11 | Citations (PDF) |
| 563 | PSA-based, prostate cancer risk on-line calculators: no such thing as a crystal ball? | 1.4 | 0 | Citations (PDF) |
| 564 | Analysis of Temporal and Causal Relationship Between Syncope and 30-Day Events in a Cohort of Emergency Department Patients to Identify the True Rate of Short-term Outcomes | 0.8 | 7 | Citations (PDF) |
| 565 | Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes | 3.6 | 4 | Citations (PDF) |
| 566 | Diagnostic biomarkers of muscle injury and exertional rhabdomyolysis | 2.4 | 50 | Citations (PDF) |
| 567 | Association of Short- and Medium-Term Particulate Matter Exposure with Risk of Mortality after Spontaneous Intracerebral Hemorrhage | 1.7 | 5 | Citations (PDF) |
| 568 | Diagnosis is now indexed in PubMed | 1.4 | 2 | Citations (PDF) |
| 569 | Car Travel-Related Thrombosis: Fact or Fiction? | 2.6 | 12 | Citations (PDF) |
| 570 | Impact of blood cell counts and volumes on glucose concentration in uncentrifuged serum and lithium-heparin blood tubes | 2.4 | 13 | Citations (PDF) |
| 571 | Natural approaches in metabolic syndrome management | 1.2 | 120 | Citations (PDF) |
| 572 | Weighting healthcare efficiency against available resources: value is the goal | 1.4 | 7 | Citations (PDF) |
| 573 | Postanalytical considerations that may improve the diagnosis or exclusion of haemophilia and von Willebrand disease | 2.0 | 5 | Citations (PDF) |
| 574 | Proteomics and frailty: a clinical overview | 2.1 | 15 | Citations (PDF) |
| 575 | Clinical Chemistry and Laboratory Medicine continues to shine brightly in the constellation of laboratory medicine | 2.4 | 0 | Citations (PDF) |
| 576 | Joint EFLM-COLABIOCLI Recommendation for venous blood sampling | 2.4 | 201 | Citations (PDF) |
| 577 | Internal quality assurance of HIL indices on Roche Cobas c702 | 2.4 | 27 | Citations (PDF) |
| 578 | Interruptions, work environment and work load perceptions in laboratory medicine: patient safety is a “moving target” | 1.4 | 0 | Citations (PDF) |
| 579 | Norbert Tietz, 13th November 1926–23rd May 2018 | 2.4 | 0 | Citations (PDF) |
| 580 | Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases | 2.4 | 104 | Citations (PDF) |
| 581 | On the complexity of hemostasis and the need for harmonization of test practice | 2.4 | 16 | Citations (PDF) |
| 582 | Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience | 1.5 | 6 | Citations (PDF) |
| 583 | Prothrombotic State Induced by Middle-Distance Endurance Exercise in Middle-Aged Athletes | 2.6 | 11 | Citations (PDF) |
| 584 | Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators | 4.0 | 32 | Citations (PDF) |
| 585 | Sudden Cardiac and Noncardiac Death in Sports: Epidemiology, Causes, Pathogenesis, and Prevention | 2.6 | 45 | Citations (PDF) |
| 586 | Is the hemolysis index always suitable for monitoring phlebotomy performance? | 0.2 | 2 | Citations (PDF) |
| 587 | “30-minute-delta” and biological variation of high-sensitivity cardiac troponin I | 2.2 | 0 | Citations (PDF) |
| 588 | Vitamin D and Gastrointestinal Cancers: A Narrative Review | 2.3 | 24 | Citations (PDF) |
| 589 | A collaborative study by the Working Group on Hemostasis and Thrombosis of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) on the interference of haemolysis on five routine blood coagulation tests by evaluation of 269 paired haemolysed/non-haemolysed samples | 1.2 | 15 | Citations (PDF) |
| 590 | Telomere length: is the future in our “ends”? | 1.8 | 7 | Citations (PDF) |
| 591 | Rare diseases: the paradox of an emerging challenge | 1.8 | 19 | Citations (PDF) |
| 592 | Red blood cell distribution width (RDW) is an independent predictor of post-implantation syndrome in patients undergoing endovascular aortic repair for abdominal aortic aneurysm | 1.8 | 8 | Citations (PDF) |
| 593 | A Preliminary Proposal for Quality Control Assessment and Harmonization of Leukocytes Morphology-Structural Parameters (Cell Population Data Parameters) | 1.9 | 16 | Citations (PDF) |
| 594 | Red blood cell distribution width in heart failure: A narrative review | 2.4 | 84 | Citations (PDF) |
| 595 | Cardiac troponins and mortality in type 1 and 2 myocardial infarction | 2.4 | 9 | Citations (PDF) |
| 596 | Limits of ventricular function: from athlete's heart to a failing heart | 1.2 | 6 | Citations (PDF) |
| 597 | The serum concentrations of leptin and MCP-1 independently predict low back pain duration | 2.4 | 19 | Citations (PDF) |
| 598 | The impact of fist clenching and its maintenance during venipuncture on routine hematology testing | 2.8 | 9 | Citations (PDF) |
| 599 | The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review | 3.9 | 8 | Citations (PDF) |
| 600 | Reporting altered test results in hemolyzed samples: is the cure worse than the disease? | 2.4 | 19 | Citations (PDF) |
| 601 | Pre-analytical phase management: a review of the procedures from patient preparation to laboratory analysis | 1.3 | 88 | Citations (PDF) |
| 602 | Non-traumatic rhabdomyolysis: Background, laboratory features, and acute clinical management | 1.9 | 112 | Citations (PDF) |
| 603 | Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE) | 2.4 | 47 | Citations (PDF) |
| 604 | Innovative software for recording preanalytical errors in accord with the IFCC quality indicators | 2.4 | 28 | Citations (PDF) |
| 605 | Managing the patient identification crisis in healthcare and laboratory medicine | 1.9 | 33 | Citations (PDF) |
| 606 | Blood venous sample collection: Recommendations overview and a checklist to improve quality | 1.9 | 78 | Citations (PDF) |
| 607 | Patient posture for blood collection by venipuncture: recall for standardization after 28 years | 1.0 | 29 | Citations (PDF) |
| 608 | Preanalytical variables for liquid chromatography-mass spectrometry (LC-MS) analysis of human blood specimens | 1.9 | 28 | Citations (PDF) |
| 609 | Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer | 3.5 | 94 | Citations (PDF) |
| 610 | Biological variation of platelet parameters determined by the Sysmex XN hematology analyzer | 1.6 | 45 | Citations (PDF) |
| 611 | Early in-hospital variation of red blood cell distribution width predicts mortality in patients with acute heart failure | 2.3 | 29 | Citations (PDF) |
| 612 | Serum Concentration of Growth Differentiation Factor-15 Is Independently Associated with Global Platelet Function and Higher Fibrinogen Values in Adult Healthy Subjects | 2.6 | 10 | Citations (PDF) |
| 613 | Can we still trust hemoglobin A1c in all situations? | 2.4 | 3 | Citations (PDF) |
| 614 | The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-AnalysisDrugs, 2017, 77, 1187-1197 | 11.8 | 36 | Citations (PDF) |
| 615 | Effect of delayed centrifugation of whole blood on serum samples stability | 0.5 | 6 | Citations (PDF) |
| 616 | Rapid and well tolerated action of idarucizumab for antagonizing dabigatran in a patient needing urgent thrombolysis | 1.0 | 17 | Citations (PDF) |
| 617 | The Intriguing Link between the Intestinal Microbiota and Cardiovascular Disease | 2.6 | 17 | Citations (PDF) |
| 618 | Critical laboratory values in hemostasis: toward consensus | 4.1 | 21 | Citations (PDF) |
| 619 | Estimating the intra- and inter-individual imprecision of manual pipetting | 2.4 | 49 | Citations (PDF) |
| 620 | Short-term effect of dark chocolate consumption on routine haemostasis testing | 3.2 | 7 | Citations (PDF) |
| 621 | Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group “Laboratory Errors and Patient Safety” project | 2.4 | 103 | Citations (PDF) |
| 622 | Thrombocytopenia and infections | 2.0 | 64 | Citations (PDF) |
| 623 | C-reactive protein as early predictor of complications after minimally invasive colorectal resection | 1.6 | 18 | Citations (PDF) |
| 624 | Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up | 2.9 | 18 | Citations (PDF) |
| 625 | Reference miRNAs for colorectal cancer: analysis and verification of current data | 3.5 | 49 | Citations (PDF) |
| 626 | Preanalytical Nonconformity Management Regarding Primary Tube Mixing in Brazil | 1.9 | 8 | Citations (PDF) |
| 627 | Short- and medium-term biological variation estimates of leukocytes extended to differential count and morphology-structural parameters (cell population data) in blood samples obtained from healthy people | 1.6 | 33 | Citations (PDF) |
| 628 | Analytical validation of Gentian NGAL particle-enhanced enhanced turbidimetric immunoassay (PETIA) | 1.1 | 14 | Citations (PDF) |
| 629 | Is Google Trends a reliable tool for digital epidemiology? Insights from different clinical settings | 2.7 | 277 | Citations (PDF) |
| 630 | Effectiveness of a Laboratory Gate-Keeping Strategy to Overcome Inappropriate Test Utilization for the Diagnosis of Heparin-Induced Thrombocytopenia | 2.6 | 8 | Citations (PDF) |
| 631 | P01.08 miRNAs in serum exosomes, as reliable non-invasive biomarkers to facilitate the clinical management of patients with gliomas | 1.1 | 0 | Citations (PDF) |
| 632 | Massive pneumomediastinum following orbital fracture | 1.7 | 7 | Citations (PDF) |
| 633 | Influence of ABO blood group on sports performance | 1.8 | 8 | Citations (PDF) |
| 634 | Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group “Laboratory Error and Patient Safety” and EFLM Task and Finish Group “Performance specifications for the extra-analytical phases” | 2.4 | 89 | Citations (PDF) |
| 635 | The Role of Red Blood Cell Distribution Width for Predicting 1-year Mortality in Patients Admitted to the Emergency Department with Severe Dyspnoea | 1.9 | 2 | Citations (PDF) |
| 636 | Patient and Sample Identification. Out of the Maze? | 1.9 | 28 | Citations (PDF) |
| 637 | Ambulatory clinical parameters and sleep respiratory events in a group of obese children unselected for respiratory problems | 2.6 | 9 | Citations (PDF) |
| 638 | Analytical evaluation of the new Beckman Coulter Access high sensitivity cardiac troponin I immunoassay | 2.4 | 32 | Citations (PDF) |
| 639 | Blood laboratory testing for early prediction of preeclampsia: chasing the finish line or at the starting blocks? | 4.1 | 11 | Citations (PDF) |
| 640 | Validation rules for blood smear revision after automated hematological testing using Mindray CAL-8000 | 2.8 | 8 | Citations (PDF) |
| 641 | Atrial fibrillation in highly trained endurance athletes — Description of a syndrome | 2.3 | 81 | Citations (PDF) |
| 642 | Opportunities and drawbacks of nonstandard body fluid analysis | 2.4 | 12 | Citations (PDF) |
| 643 | Red Blood Cell Distribution Width Is an Independent Predictor of Outcome in Patients Undergoing Thrombolysis for Ischemic Stroke | 2.6 | 63 | Citations (PDF) |
| 644 | Order of blood draw: Opinion Paper by the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) | 2.4 | 62 | Citations (PDF) |
| 645 | Repeated Potassium Testing in Hemolyzed Specimens Collected in the Emergency Department: More Pros Than Cons | 0.8 | 1 | Citations (PDF) |
| 646 | Acute effect of dark chocolate on red blood cell distribution width | 2.9 | 3 | Citations (PDF) |
| 647 | Novel Opportunities for Improving the Quality of Preanalytical Phase. A Glimpse to the Future? | 1.9 | 23 | Citations (PDF) |
| 648 | Reference ranges in hemostasis testing: necessary but imperfect | 0.7 | 6 | Citations (PDF) |
| 649 | Laboratory monitoring of direct oral anticoagulants (DOACs)—The perfect storm? | 1.8 | 15 | Citations (PDF) |
| 650 | Cancer diagnostics: current concepts and future perspectives | 1.8 | 23 | Citations (PDF) |
| 651 | Direct oral anticoagulants: analysis of worldwide use and popularity using Google Trends | 1.8 | 80 | Citations (PDF) |
| 652 | From laboratory instrumentation to physician’s brain calibration: the next frontier for improving diagnostic accuracy? | 0.7 | 4 | Citations (PDF) |
| 653 | The alcohol used for cleansing the venipuncture site does not jeopardize blood and plasma alcohol measurement with head-space gas chromatography and an enzymatic assay | 1.2 | 18 | Citations (PDF) |
| 654 | Blood tubes should be labeled before drawing blood | 0.5 | 4 | Citations (PDF) |
| 655 | Role of emergency department observation units in the management of patients with unexplained syncope: a critical review and meta-analysis | 1.6 | 11 | Citations (PDF) |
| 656 | Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in<i>Pseudomonas aeruginosa</i>Infection of Cystic Fibrosis Bronchial Epithelial Cells | 3.8 | 19 | Citations (PDF) |
| 657 | Red blood cell distribution width in patients with limb, chest and head trauma | 1.2 | 16 | Citations (PDF) |
| 658 | Exploring the iceberg of inappropriateness in hemostasis testing | 1.4 | 6 | Citations (PDF) |
| 659 | Laboratory testing in the emergency department: An Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) and Academy of Emergency Medicine and Care (AcEMC) consensus report | 0.2 | 4 | Citations (PDF) |
| 660 | Clinical presentation and epidemiology of brain tumors firstly diagnosed in adults in the Emergency Department: a 10-year, single center retrospective study | 1.8 | 40 | Citations (PDF) |
| 661 | Exercising recommendations for paroxysmal AF in young and middle-aged athletes (PAFIYAMA) syndrome | 1.8 | 6 | Citations (PDF) |
| 662 | Popularity of Medicine and Laboratory Medicine journals: analysis of impact factor and popularity using Google Trends | 0.7 | 1 | Citations (PDF) |
| 663 | Uncertainty, quality, safety and accreditation in laboratory medicine | 0.7 | 5 | Citations (PDF) |
| 664 | Academy of Emergency Medicine and Care-Society of Clinical Biochemistry and Clinical Molecular Biology consensus recommendations for clinical use of sepsis biomarkers in the emergency department | 0.2 | 9 | Citations (PDF) |
| 665 | High-sensitivity cardiac troponin I immunoassay reduces the chance of patient misclassification in the emergency department | 0.7 | 0 | Citations (PDF) |
| 666 | Harmonization of red blood cell distribution width (RDW): an attainable target? | 0.5 | 1 | Citations (PDF) |
| 667 | A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker | 2.6 | 158 | Citations (PDF) |
| 668 | Association between short- and medium-term air pollution exposure and risk of mortality after intravenous thrombolysis for stroke | 2.0 | 6 | Citations (PDF) |
| 669 | Establishing the upper reference limit of Galectin-3 in healthy blood donors | 1.2 | 29 | Citations (PDF) |
| 670 | Urinary free cortisol assessment by liquid chromatography tandem mass spectrometry: a case study of ion suppression due to unacquainted administration of piperacillin | 1.2 | 7 | Citations (PDF) |
| 671 | Acutely developing, spurious anaemia without actual blood loss. A paradigmatic case report | 1.2 | 6 | Citations (PDF) |
| 672 | Impact of experimental hypercalcemia on routine haemostasis testing | 2.4 | 9 | Citations (PDF) |
| 673 | Analytical evaluation of three enzymatic assays for measuring total bile acids in plasma using a fully-automated clinical chemistry platform | 2.4 | 28 | Citations (PDF) |
| 674 | Middle-distance running acutely influences the concentration and composition of serum bile acids: Potential implications for cancer risk? | 1.7 | 40 | Citations (PDF) |
| 675 | Inappropriateness in laboratory medicine: an elephant in the room? | 1.8 | 33 | Citations (PDF) |
| 676 | Emerging treatments for hemophilia: patients and their treaters spoilt for choice, but laboratories face a difficult path? | 1.8 | 6 | Citations (PDF) |
| 677 | Translational aspects of developmental hemostasis: infants and children are not miniature adults and even adults may be different | 1.8 | 29 | Citations (PDF) |
| 678 | Mobile phone radiofrequency exposure has no effect on DNA double strand breaks (DSB) in human lymphocytes | 1.8 | 14 | Citations (PDF) |
| 679 | Overcoming preanalytical issues for diagnosing diabetes with fasting plasma glucose | 1.8 | 7 | Citations (PDF) |
| 680 | Scientist impact factor (SIF): a new metric for improving scientists’ evaluation? | 1.8 | 23 | Citations (PDF) |
| 681 | BRCA population screening for predicting breast cancer: for or against? | 1.8 | 22 | Citations (PDF) |
| 682 | Run for Science (R4S): the history of a successful project of precision and laboratory medicine in sport and exercise | 0.7 | 17 | Citations (PDF) |
| 683 | Modulation of Heart Rate by Acute or Chronic Aerobic Exercise. Potential Effects on Blood Pressure Control | 2.4 | 7 | Citations (PDF) |
| 684 | Laboratory Monitoring or Measurement of Direct Oral Anticoagulants (DOACs): Advantages, Limitations and Future Challenges | 1.2 | 47 | Citations (PDF) |
| 685 | Prognostic significance of red blood cell distribution width in gastrointestinal disorders | 4.8 | 59 | Citations (PDF) |
| 686 | Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities | 4.8 | 41 | Citations (PDF) |
| 687 | Obstructive sleep-disordered breathing, enuresis and combined disorders in children: chance or related association? | 1.6 | 12 | Citations (PDF) |
| 688 | Management of hemolyzed specimens | 0.3 | 2 | Citations (PDF) |
| 689 | How do I write a scientific article?—A personal perspective | 1.8 | 10 | Citations (PDF) |
| 690 | Reflections on the next generation of hemostasis instrumentation. A glimpse into the future? | 0.2 | 6 | Citations (PDF) |
| 691 | Epidemiology and outcomes of acute abdominal pain in a large urban Emergency Department: retrospective analysis of 5,340 cases | 1.8 | 244 | Citations (PDF) |
| 692 | The future of laboratory medicine in the era of precision medicine | 0.7 | 20 | Citations (PDF) |
| 693 | Clinical significance of cell population data (CPD) on Sysmex XN-9000 in septic patients with our without liver impairment | 1.8 | 53 | Citations (PDF) |
| 694 | Effects of 12‐Week Endurance Training at Natural Low Altitude on the Blood Redox Homeostasis of Professional Adolescent Athletes: A Quasi‐Experimental Field Trial | 4.6 | 5 | Citations (PDF) |
| 695 | Standardizing in vitro diagnostics tasks in clinical trials: a call for action | 1.8 | 26 | Citations (PDF) |
| 696 | Critical laboratory values communication: summary recommendations from available guidelines | 1.8 | 30 | Citations (PDF) |
| 697 | Red blood cell distribution width independently predicts medium-term mortality and major adverse cardiac events after an acute coronary syndrome | 1.8 | 28 | Citations (PDF) |
| 698 | Does fist pumping/clenching during venipuncture activate blood coagulation? | 1.0 | 6 | Citations (PDF) |
| 699 | Heart-type fatty acid-binding protein after ultramarathon running and relationship with high-sensitivity troponin I | 1.2 | 1 | Citations (PDF) |
| 700 | Analytical Evaluation of Free Testosterone and Cortisol Immunoassays in Saliva as a Reliable Alternative to Serum in Sports Medicine | 2.8 | 24 | Citations (PDF) |
| 701 | Short‐term Prognosis and Current Management of Syncopal Patients at Intermediate Risk: Results from the IRiS (Intermediate‐Risk Syncope) Study | 1.7 | 17 | Citations (PDF) |
| 702 | Spurious elevation of serum potassium concentration measured in samples with thrombocytosis | 1.4 | 6 | Citations (PDF) |
| 703 | DNA injury is acutely enhanced in response to increasing bulks of aerobic physical exercise | 1.6 | 13 | Citations (PDF) |
| 704 | Comparison of the novel Maglumi ferritin immunoluminometric assay with Beckman Coulter DxI 800 ferritin | 0.2 | 6 | Citations (PDF) |
| 705 | Cardiac Troponin I Is Increased in Patients with Polytrauma and Chest or Head Trauma. Results of A Retrospective Case-Control Study | 1.9 | 14 | Citations (PDF) |
| 706 | Assessment of reticulated platelets with automated hemocytometers: are we measuring the same thing? | 1.4 | 4 | Citations (PDF) |
| 707 | Mefloquine-associated rhabdomyolysis | 1.7 | 7 | Citations (PDF) |
| 708 | Allergy and Venous Thromboembolism: A Casual or Causative Association | 2.6 | 13 | Citations (PDF) |
| 709 | Cardiospecific troponin immunoassays: How low is it worth to go? | 2.9 | 9 | Citations (PDF) |
| 710 | Laboratory economics. Risk or opportunity? | 2.4 | 14 | Citations (PDF) |
| 711 | No correlation between health care expenditure and mortality in the European Union | 2.9 | 18 | Citations (PDF) |
| 712 | Wasp venom allergy screening with recombinant allergen testing. Diagnostic performance of rPol d 5 and rVes v 5 for differentiating sensitization to Vespula and Polistes subspecies | 1.6 | 31 | Citations (PDF) |
| 713 | Factor XII in Hemostasis and Thrombosis: Active Player or (Innocent) Bystander? | 2.6 | 17 | Citations (PDF) |
| 714 | Protein S100B: from cancer diagnostics to the evaluation of mild traumatic brain injury | 2.4 | 4 | Citations (PDF) |
| 715 | Improving diagnosis and reducing diagnostic errors: the next frontier of laboratory medicine | 2.4 | 28 | Citations (PDF) |
| 716 | The role of European Federation of Clinical Chemistry and Laboratory Medicine Working Group for Preanalytical Phase in standardization and harmonization of the preanalytical phase in Europe | 2.0 | 38 | Citations (PDF) |
| 717 | Chest pain, dyspnea and other symptoms in patients with type 1 and 2 myocardial infarction. A literature review | 2.3 | 46 | Citations (PDF) |
| 718 | Correlation between ABO Blood Group, and Conventional Hematological and Metabolic Parameters in Blood Donors | 2.6 | 18 | Citations (PDF) |
| 719 | Diagnostics of Inherited Bleeding Disorders of Secondary Hemostasis: An Easy Guide for Routine Clinical Laboratories | 2.6 | 33 | Citations (PDF) |
| 720 | The Mean Platelet Volume Is Decreased in Patients Diagnosed with Venous Thromboembolism in the Emergency Department | 2.6 | 21 | Citations (PDF) |
| 721 | Red blood cell distribution width and haemoglobin are associated with hospital admission in patients with acute allergic reactions | 2.1 | 6 | Citations (PDF) |
| 722 | Mobile phone exposure influences some erythrocytes parameters in vitro. A novel source of preanalytical variability? | 1.4 | 0 | Citations (PDF) |
| 723 | Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – Some answers and still many questions | 5.8 | 47 | Citations (PDF) |
| 724 | Genetic and nongenetic determinants of mean platelet volumeBlood, 2016, 127, 179-180 | 4.2 | 13 | Citations (PDF) |
| 725 | Optimization of Cellular analysis of Synovial Fluids by optical microscopy and automated count using the Sysmex XN Body Fluid Mode | 1.6 | 21 | Citations (PDF) |
| 726 | Critical pre-examination variables in the hemostasis laboratory and their quality indicators | 1.9 | 36 | Citations (PDF) |
| 727 | The impact of different sample matrices in delayed measurement of glucose | 1.9 | 6 | Citations (PDF) |
| 728 | Analytical evaluation of the novel Lumipulse G BRAHMS procalcitonin immunoassay | 1.1 | 9 | Citations (PDF) |
| 729 | Serum myoglobin immunoassays: obsolete or still clinically useful? | 2.4 | 10 | Citations (PDF) |
| 730 | Monitoring B-type natriuretic peptide in patients undergoing therapy with neprilysin inhibitors. An emerging challenge? | 2.3 | 20 | Citations (PDF) |
| 731 | Assessment of blood sample stability for complete blood count using the Sysmex XN-9000 and Mindray BC-6800 analyzers | 1.0 | 33 | Citations (PDF) |
| 732 | Estimation of the imprecision on clinical chemistry testing due to fist clenching and maintenance during venipuncture | 1.9 | 29 | Citations (PDF) |
| 733 | Practices for Identifying and Rejecting Hemolyzed Specimens in Europe | 2.5 | 5 | Citations (PDF) |
| 734 | Prevention of inhibitor development in hemophilia A in 2016. A glimpse into the future? | 2.4 | 10 | Citations (PDF) |
| 735 | Mixing of thawed coagulation samples prior to testing: Is any technique better than another? | 1.9 | 15 | Citations (PDF) |
| 736 | Access to scientific information. A national survey of the Italian Society of Clinical Biochemistry and Laboratory Medicine (SIBioC) | 1.4 | 0 | Citations (PDF) |
| 737 | Patient identification and tube labelling – a call for harmonisation | 2.4 | 47 | Citations (PDF) |
| 738 | Transient Receptor Potential Ankyrin 1 Channels Modulate Inflammatory Response in Respiratory Cells from Patients with Cystic Fibrosis | 4.3 | 39 | Citations (PDF) |
| 739 | Vegetables intake and venous thromboembolism | 1.0 | 2 | Citations (PDF) |
| 740 | Fish Intake and Venous Thromboembolism | 1.9 | 7 | Citations (PDF) |
| 741 | How to report results of prothrombin and activated partial thromboplastin times | 2.4 | 29 | Citations (PDF) |
| 742 | Integration of Diagnostic Microbiology in a Model of Total Laboratory Automation | 1.0 | 28 | Citations (PDF) |
| 743 | Low serum bilirubin values are associated with pulmonary embolism in a case-control study | 2.4 | 14 | Citations (PDF) |
| 744 | Meat consumption and cancer risk: a critical review of published meta-analyses | 5.2 | 168 | Citations (PDF) |
| 745 | Spring season birth is associated with higher emergency department admission for acute allergic reactions | 2.9 | 4 | Citations (PDF) |
| 746 | Analytical imprecision of lactate dehydrogenase in primary serum tubes | 2.0 | 1 | Citations (PDF) |
| 747 | Building a bridge to safe diagnosis in health care. The role of the clinical laboratory | 2.4 | 45 | Citations (PDF) |
| 748 | Birth season predicts the values of red blood cell distribution width (RDW) in adulthood | 2.4 | 3 | Citations (PDF) |
| 749 | Relative Risks of Thrombosis and Bleeding in Different ABO Blood Groups | 2.6 | 40 | Citations (PDF) |
| 750 | Thirty-minutes’ exposure to smartphone call triggers neutrophil activation in vitro | 2.4 | 8 | Citations (PDF) |
| 751 | Capillary electrophoresis for the screening and diagnosis of inherited hemoglobin disorders. Ready for prime time? | 2.4 | 12 | Citations (PDF) |
| 752 | Idiopathic Calcium Nephrolithiasis and Hypovitaminosis D: A Case-control Study | 1.5 | 33 | Citations (PDF) |
| 753 | EFLM WG-Preanalytical phase opinion paper: local validation of blood collection tubes in clinical laboratories | 2.4 | 53 | Citations (PDF) |
| 754 | Macroprolactin: searching for a needle in a haystack? | 2.4 | 24 | Citations (PDF) |
| 755 | Cell Population Data and reflex testing rules of cell analysis in pleural and ascitic fluids using body fluid mode on Sysmex XN-9000 | 1.6 | 30 | Citations (PDF) |
| 756 | Reflex Testing Rules for Cell Count and Differentiation of Nucleated Elements in Pleural and Ascitic Fluids on Sysmex XE-5000 | 3.5 | 14 | Citations (PDF) |
| 757 | Early function decline after ischemic stroke can be predicted by a nomogram based on age, use of thrombolysis, RDW and NIHSS score at admission | 2.0 | 45 | Citations (PDF) |
| 758 | Blood Sampling Seasonality as an Important Preanalytical Factor for Assessment of Vitamin D Status | 1.9 | 26 | Citations (PDF) |
| 759 | Biological samples transportation by drones: ready for prime time? | 1.8 | 45 | Citations (PDF) |
| 760 | High-density lipoprotein cholesterol values independently and inversely predict cardiac troponin T and I concentration | 1.8 | 4 | Citations (PDF) |
| 761 | Acute coronary syndrome: many doubts, some answers | 1.8 | 4 | Citations (PDF) |
| 762 | Diagnostic algorithms for acute coronary syndrome—is one better than another? | 1.8 | 38 | Citations (PDF) |
| 763 | Clinical perception and simple laboratory tests: do not mistake the finger pointing at the moon | 1.8 | 2 | Citations (PDF) |
| 764 | High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages | 1.8 | 17 | Citations (PDF) |
| 765 | Troubleshooting an isolate prolongation of activated partial thromboplastin time in a patient with acute myocardial infarction—a paradigmatic case report | 1.8 | 4 | Citations (PDF) |
| 766 | The interplay between genetics, epigenetics and environment in modulating the risk of coronary heart disease | 1.8 | 6 | Citations (PDF) |
| 767 | PAFIYAMA syndrome: prevention is better than cure | 0.7 | 3 | Citations (PDF) |
| 768 | Elevated fibrinogen plasma level is not an independent predictor of poor prognosis in a large cohort of Western patients undergoing surgery for colorectal cancer | 4.8 | 21 | Citations (PDF) |
| 769 | Pre-examination procedures in laboratory diagnostics | 0.2 | 0 | Citations (PDF) |
| 770 | Evidence and pitfalls in diagnosis and prognostication of acute coronary syndrome | 1.8 | 0 | Citations (PDF) |
| 771 | Predictive significance of detectable cardiac troponin I measured with a contemporary-sensitive assay in a real life experience | 1.8 | 1 | Citations (PDF) |
| 772 | Column in laboratory medicine | 1.8 | 2 | Citations (PDF) |
| 773 | Streamlining laboratory expenditures through direct to consumer testing and reference prices: first do not harm | 1.8 | 1 | Citations (PDF) |
| 774 | Multicenter Comparison of Seven 25Oh Vitamin D Automated Immunoassays / Multicentrično Poređenje Sedam Automatizovanih Imunoeseja Za 25Oh Vitamin D | 1.9 | 5 | Citations (PDF) |
| 775 | Laboratory Diagnostics and Quality of Blood Collection / Laboratorijska Dijagnostika I Kvalitet Uzimanja Uzoraka Krvi | 1.9 | 92 | Citations (PDF) |
| 776 | Association Of Hyponatremia And Hypovitaminosis D In Ambulatory Adults | 1.9 | 7 | Citations (PDF) |
| 777 | A case of factitious hyponatremia and hypokalemia due to the presence of fibrin gel in serum | 1.4 | 8 | Citations (PDF) |
| 778 | Laboratory medicine does matter in science (and medicine)… yet many seem to ignore it | 2.4 | 16 | Citations (PDF) |
| 779 | Alcohol consumption and venous thromboembolism: friend or foe? | 3.2 | 19 | Citations (PDF) |
| 780 | Influence of Air Temperature Variations on Incidence of Epistaxis | 2.3 | 27 | Citations (PDF) |
| 781 | Serum Copeptin and Midregion Proadrenomedullin (MR‐proADM) After an Ultramarathon | 2.8 | 15 | Citations (PDF) |
| 782 | How we define hyponatraemia? | 3.3 | 1 | Citations (PDF) |
| 783 | Venous stasis and whole blood platelet aggregometry | 1.0 | 14 | Citations (PDF) |
| 784 | Cell-free DNA for diagnosing myocardial infarction: not ready for prime time | 2.4 | 16 | Citations (PDF) |
| 785 | Cardiac troponin I is increased in patients admitted to the emergency department with severe allergic reactions. A case–control study | 2.3 | 44 | Citations (PDF) |
| 786 | The degree of acceptability of swine blood values at increasing levels of hemolysis evaluated through visual inspection versus automated quantification | 1.5 | 10 | Citations (PDF) |
| 787 | Analytical evaluation of Diazyme procalcitonin (PCT) latex-enhanced immunoturbidimetric assay on Beckman Coulter AU5800 | 2.4 | 29 | Citations (PDF) |
| 788 | Ranking prestige of medical and laboratory technology journals | 2.4 | 5 | Citations (PDF) |
| 789 | Laboratory biomarkers and frailty: presentation of the FRAILOMIC initiative | 2.4 | 19 | Citations (PDF) |
| 790 | Adjustment of serum potassium for age and platelet count. A simple step forward towards personalized medicine | 2.4 | 9 | Citations (PDF) |
| 791 | Red blood cell distribution width: A simple parameter with multiple clinical applications | 5.8 | 1,000 | Citations (PDF) |
| 792 | Advantages and Pitfalls of Fructosamine and Glycated Albumin in the Diagnosis and Treatment of Diabetes | 3.2 | 182 | Citations (PDF) |
| 793 | Influence of spurious dilution and hyperglycemia on erythrocytes and platelets evaluated with two different hematological analyzers | 1.9 | 0 | Citations (PDF) |
| 794 | The mean platelet volume is significantly associated with higher glycated hemoglobin in a large population of unselected outpatients | 2.0 | 28 | Citations (PDF) |
| 795 | Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus? | 2.4 | 91 | Citations (PDF) |
| 796 | Diagnostics in Venous Thromboembolism: From Origin to Future Prospects | 2.6 | 18 | Citations (PDF) |
| 797 | Sleep apnea and venous thromboembolism | 4.2 | 52 | Citations (PDF) |
| 798 | International Survey on D-Dimer Test Reporting: A Call for Standardization | 2.6 | 69 | Citations (PDF) |
| 799 | Analytical assessment of the novel homocysteine liquid enzymatic assay on Beckman Coulter AU5800 | 2.4 | 1 | Citations (PDF) |
| 800 | Multicenter comparison of automated procalcitonin immunoassays | 1.1 | 50 | Citations (PDF) |
| 801 | Effectiveness of a computerized alert system based on re-testing intervals for limiting the inappropriateness of laboratory test requests | 1.9 | 41 | Citations (PDF) |
| 802 | Colour coding for blood collection tube closures – a call for harmonisation | 2.4 | 25 | Citations (PDF) |
| 803 | Personalized medicine: moving from simple theory to daily practice | 2.4 | 18 | Citations (PDF) |
| 804 | The use of S-Monovette is effective to reduce the burden of hemolysis in a large urban emergency department | 1.2 | 17 | Citations (PDF) |
| 805 | Red meat, processed meat and the risk of venous thromboembolism: Friend or foe? | 2.4 | 4 | Citations (PDF) |
| 806 | What Do Hemolyzed Whole-Blood Specimens Look Like? Analysis with a CellaVision DM96 Automated Image Analysis System | 0.8 | 9 | Citations (PDF) |
| 807 | Compliance of blood sampling procedures with the CLSI H3-A6 guidelines: An observational study by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PRE) | 2.4 | 81 | Citations (PDF) |
| 808 | Neurofilament medium polypeptide (NFM) protein concentration is increased in CSF and serum samples from patients with brain injury | 2.4 | 58 | Citations (PDF) |
| 809 | Cylindruria | 2.4 | 17 | Citations (PDF) |
| 810 | Laboratory Testing in the Era of Direct or Non–Vitamin K Antagonist Oral Anticoagulants: A Practical Guide to Measuring Their Activity and Avoiding Diagnostic Errors | 2.6 | 99 | Citations (PDF) |
| 811 | Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE) | 2.4 | 127 | Citations (PDF) |
| 812 | Next Generation Antithrombotic Therapy: Focus on Antisense Therapy against Coagulation Factor XI | 2.6 | 15 | Citations (PDF) |
| 813 | Quality and Safety Issues of Direct Oral Anticoagulants in the Emergency Department | 2.6 | 12 | Citations (PDF) |
| 814 | The Changing Face of Hemostasis Testing in Modern Laboratories: Consolidation, Automation, and Beyond | 2.6 | 21 | Citations (PDF) |
| 815 | Fried food consumption and ischemic heart disease | 2.3 | 7 | Citations (PDF) |
| 816 | Galectin-3 in atrial fibrillation: Simple bystander, player or both? | 1.9 | 31 | Citations (PDF) |
| 817 | The baseline serum value of α-amylase is a significant predictor of distance running performance | 2.4 | 10 | Citations (PDF) |
| 818 | Meta-analysis of factor V Leiden and prothrombin G20210A polymorphism in migraine | 1.0 | 12 | Citations (PDF) |
| 819 | Newer Hemostatic Agents | 2.6 | 20 | Citations (PDF) |
| 820 | Hs-cTnT levels in professional soccer players throughout a season: No evidence of sustained cardiac damage | 2.3 | 3 | Citations (PDF) |
| 821 | Usefulness of suPAR in the risk stratification of patients with sepsis admitted to the emergency department | 3.2 | 32 | Citations (PDF) |
| 822 | Comparison of nucleated red blood cell count with four commercial hematological analyzers | 2.4 | 9 | Citations (PDF) |
| 823 | Mean platelet volume is significantly associated with serum levels of thyroid-stimulating hormone in a cohort of older euthyroid subjects | 2.7 | 10 | Citations (PDF) |
| 824 | Detection of mild inherited disorders of blood coagulation: current options and personal recommendations | 2.0 | 33 | Citations (PDF) |
| 825 | Biomarkers of inflammatory bowel disease: ready for prime time? | 2.4 | 0 | Citations (PDF) |
| 826 | Severe allergic reaction, adrenaline, and the heart. Out of the maze? | 2.3 | 2 | Citations (PDF) |
| 827 | Postural change during venous blood collection is a major source of bias in clinical chemistry testing | 1.6 | 53 | Citations (PDF) |
| 828 | Comparison of Genetic and Epigenetic Alterations of Primary Tumors and Matched Plasma Samples in Patients with Colorectal Cancer | 2.4 | 41 | Citations (PDF) |
| 829 | The biomarker paradigm: between diagnostic efficiency and clinical efficacy | 0.6 | 25 | Citations (PDF) |
| 830 | Gum-Chewing and Headache: An Underestimated Trigger of Headache Pain in Migraineurs? | 2.4 | 1 | Citations (PDF) |
| 831 | Serum bilirubin value predicts hospital admission in carbon monoxide-poisoned patients. Active player or simple bystander? | 1.9 | 6 | Citations (PDF) |
| 832 | “Real life use” of troponin in the emergency department: a survey of over 3000 cases | 1.2 | 5 | Citations (PDF) |
| 833 | Il dosaggio ematico dei farmaci antidiabetici: importanza nelle sindromi ipoglicemiche | 0.0 | 0 | Citations (PDF) |
| 834 | Biomarker validation in the emergency department. General criteria and clinical implications | 0.2 | 1 | Citations (PDF) |
| 835 | Serum Potassium Levels Inversely Correlate with D-Dimer In Patients with Acute-Onset Atrial Fibrillation | 0.7 | 4 | Citations (PDF) |
| 836 | Processing of Diagnostic Blood Specimens: Is It Really Necessary to Mix Primary Blood Tubes after Collection with Evacuated Tube System? | 1.5 | 19 | Citations (PDF) |
| 837 | Physical activity - an important preanalytical variable | 1.2 | 55 | Citations (PDF) |
| 838 | Multicenter Comparison of Four Contemporary Sensitive Troponin Immunoassays | 1.9 | 3 | Citations (PDF) |
| 839 | No Evidence for an Association of Vitamin D Deficiency and Migraine: A Systematic Review of the Literature | 2.5 | 19 | Citations (PDF) |
| 840 | Interference of medical contrast media on laboratory testing | 1.2 | 46 | Citations (PDF) |
| 841 | Technological Advances in the Hemostasis Laboratory | 2.6 | 27 | Citations (PDF) |
| 842 | Dangers in the Practice of Defensive Medicine in Hemostasis Testing for Investigation of Bleeding or Thrombosis: Part I—Routine Coagulation Testing | 2.6 | 27 | Citations (PDF) |
| 843 | The mystifying nomenclature of cardiac troponin immunoassays | 1.3 | 7 | Citations (PDF) |
| 844 | Of MIs and Men—A Historical Perspective on the Diagnostics of Acute Myocardial Infarction | 2.6 | 42 | Citations (PDF) |
| 845 | Aging Hemostasis: Changes to Laboratory Markers of Hemostasis As We Age—A Narrative Review | 2.6 | 131 | Citations (PDF) |
| 846 | A Review of the Value of D-dimer Testing for Prediction of Recurrent Venous Thromboembolism with Increasing Age | 2.6 | 25 | Citations (PDF) |
| 847 | Biomarkers in the emergency department. Handle with care | 2.4 | 2 | Citations (PDF) |
| 848 | Circulating cardiac troponin T is not influenced by postural changes during venous blood collection | 2.3 | 7 | Citations (PDF) |
| 849 | Interference from heterophilic antibodies in D-dimer assessment. A case report | 1.0 | 20 | Citations (PDF) |
| 850 | Blood Collection From Intravenous Lines: Is One Drawing Site Better Than Others? | 1.0 | 18 | Citations (PDF) |
| 851 | Mean Platelet Volume (MPV) Predicts Middle Distance Running Performance | 2.4 | 43 | Citations (PDF) |
| 852 | Laboratory preparedness to face infectious outbreaks. Ebola and beyond | 2.4 | 10 | Citations (PDF) |
| 853 | A short story on how the H-index may change the fate of scientists and scientific publishing | 2.4 | 9 | Citations (PDF) |
| 854 | Do we really need high-sensitivity troponin immunoassays in the emergency department? Maybe not | 2.4 | 17 | Citations (PDF) |
| 855 | Red blood cell distribution width is significantly associated with aging and gender | 2.4 | 61 | Citations (PDF) |
| 856 | Stat testing utilization in clinical laboratories. National survey of Italian Society of Clinical Biochemistry and Molecular Biology (SIBioC) | 2.4 | 9 | Citations (PDF) |
| 857 | The quality of diagnostic testing may be impaired during shipment of lithium-heparin gel tubes | 2.4 | 8 | Citations (PDF) |
| 858 | Variation of Red Blood Cell Distribution Width and Mean Platelet Volume after Moderate Endurance Exercise | 1.5 | 48 | Citations (PDF) |
| 859 | Prevalence of Hyponatremia in Femur Neck Fractures: A One-Year Survey in an Urban Emergency Department | 1.6 | 13 | Citations (PDF) |
| 860 | Could light meal jeopardize laboratory coagulation tests? | 1.2 | 28 | Citations (PDF) |
| 861 | Contamination of lithium heparin blood by K2-ethylenediaminetetraacetic acid (EDTA): an experimental evaluation | 1.2 | 19 | Citations (PDF) |
| 862 | Thrombophilia testing. Useful or hype? | 2.4 | 7 | Citations (PDF) |
| 863 | Point of care testing: evolving scenarios and innovative perspectives | 2.4 | 24 | Citations (PDF) |
| 864 | C-reactive protein and migraine. Facts or speculations? | 2.4 | 47 | Citations (PDF) |
| 865 | Red blood cell distribution width (RDW) and human pathology. One size fits all | 2.4 | 169 | Citations (PDF) |
| 866 | Dipyridamole Stress Echocardiography Does Not Trigger Release of Highly-Sensitive Troponin I and T | 1.9 | 1 | Citations (PDF) |
| 867 | D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL | 2.4 | 41 | Citations (PDF) |
| 868 | Calprotectin and cardiovascular events. A narrative review | 1.9 | 15 | Citations (PDF) |
| 869 | Incidence of acute-onset atrial fibrillation correlates with air temperature. Results of a nine-year survey | 2.7 | 27 | Citations (PDF) |
| 870 | Thyroid hormone levels are associated with anisocytosis in a cohort of euthyroid older outpatients | 2.9 | 7 | Citations (PDF) |
| 871 | Evaluation of the current prognostic role of heart diseases in the history of patients with syncope | 2.1 | 16 | Citations (PDF) |
| 872 | Erythropoietin and the heart: Physiological effects and the therapeutic perspective | 2.3 | 55 | Citations (PDF) |
| 873 | Laboratory diagnostics of spontaneous bacterial peritonitis | 1.6 | 23 | Citations (PDF) |
| 874 | Acetaminophen and sport performance: doping or what? | 2.0 | 8 | Citations (PDF) |
| 875 | Harmonization of contemporary-sensitive troponin I immunoassays: calibration may only be a part of the problem | 0.5 | 2 | Citations (PDF) |
| 876 | Homocysteine and migraine. A narrative review | 1.6 | 42 | Citations (PDF) |
| 877 | The ten commandments of laboratory testing for emergency physicians | 2.4 | 11 | Citations (PDF) |
| 878 | Urgent monitoring of direct oral anticoagulants in patients with atrial fibrillation: a tentative approach based on routine laboratory tests | 2.0 | 34 | Citations (PDF) |
| 879 | Risk assessment of post-infarction heart failure. Systematic review on the role of emerging biomarkers | 5.8 | 43 | Citations (PDF) |
| 880 | Genetic polymorphisms of human cardiac troponins as an unrecognized challenge for diagnosing myocardial injury | 2.3 | 10 | Citations (PDF) |
| 881 | Thrombophilia testing in patients taking direct oral anticoagulants. Handle with care | 1.4 | 16 | Citations (PDF) |
| 882 | Influence of training and a maximal exercise test in analytical variability of muscular, hepatic, and cardiovascular biochemical variables | 1.3 | 18 | Citations (PDF) |
| 883 | Analytical assessment of the Beckman Coulter Unicel DxI AccuTnI+3 immunoassay | 1.4 | 13 | Citations (PDF) |
| 884 | Initial blood lactate correlates with carboxyhemoglobin and clinical severity in carbon monoxide poisoned patients | 1.9 | 35 | Citations (PDF) |
| 885 | Hypercoagulability, D-dimer and atrial fibrillation: an overview of biological and clinical evidence | 4.1 | 55 | Citations (PDF) |
| 886 | Immunoglobulin E (IgE) and ischemic heart disease. Which came first, the chicken or the egg? | 4.1 | 29 | Citations (PDF) |
| 887 | Mean speed in professional cycling: No evidence of decline | 2.1 | 3 | Citations (PDF) |
| 888 | A false positive case of cardiac troponin I identified with CK-MB reflex testing | 2.3 | 8 | Citations (PDF) |
| 889 | The concentration of high-sensitivity troponin I, galectin-3 and NT-proBNP substantially increase after a 60-km ultramarathon | 2.4 | 38 | Citations (PDF) |
| 890 | Check-in and Sorting of Centrifuged Serum and Lithium-Heparin Tubes May Be Unsuitable Using a Bulk Input Module | 0.8 | 1 | Citations (PDF) |
| 891 | Adiponectin and migraine: systematic review of clinical evidence | 1.7 | 12 | Citations (PDF) |
| 892 | Do clinicians decide relying primarily on Bayesians principles or on Gestalt perception? Some pearls and pitfalls of Gestalt perception in medicine | 3.2 | 60 | Citations (PDF) |
| 893 | Lack of association of the mean platelet volume with plasma lipids in a general population of unselected outpatients | 0.5 | 2 | Citations (PDF) |
| 894 | Praticare l’appropriatezza: il caso della troponina | 0.5 | 0 | Citations (PDF) |
| 895 | Reference range of hemolysis index in serum and lithium-heparin plasma measured with two analytical platforms in a population of unselected outpatients | 1.6 | 50 | Citations (PDF) |
| 896 | Causes of elevated D-dimer in patients admitted to a large urban emergency department | 2.9 | 137 | Citations (PDF) |
| 897 | Relationship between serum galectin-3 values and demographical or biochemical variables in patients without acute coronary syndrome | 2.3 | 4 | Citations (PDF) |
| 898 | Standardization of collection requirements for fasting samples | 1.6 | 145 | Citations (PDF) |
| 899 | Low volume tubes are not effective to reduce the rate of hemolyzed specimens from the emergency department | 1.9 | 13 | Citations (PDF) |
| 900 | The concentration of troponin I is increased in patients with acute-onset atrial fibrillation | 2.3 | 12 | Citations (PDF) |
| 901 | Relationship between body weight and total weight lifted in the 2013 World Weightlifting Championships | 2.1 | 6 | Citations (PDF) |
| 902 | A four-year survey on unexpected pregnancy diagnoses in a large urban emergency department in Parma, Italy | 1.9 | 6 | Citations (PDF) |
| 903 | Inversion of lithium heparin gel tubes after centrifugation is a significant source of bias in clinical chemistry testing | 1.6 | 22 | Citations (PDF) |
| 904 | Lack of harmonization of red blood cell distribution width (RDW). Evaluation of four hematological analyzers | 1.9 | 108 | Citations (PDF) |
| 905 | Less is more, but do not throw out the baby with the bathwater either! | 1.4 | 4 | Citations (PDF) |
| 906 | Epidemiological association between migraine and lipoprotein(a): a systematic review | 2.0 | 3 | Citations (PDF) |
| 907 | Effects of allopurinol on exercise-induced muscle damage: new therapeutic approaches? | 2.7 | 24 | Citations (PDF) |
| 908 | Biological Markers in Older People at Risk of Mobility Limitations | 2.4 | 28 | Citations (PDF) |
| 909 | Early kinetics of heart-type fatty acid binding protein in patients undergoing dipyridamole stress echocardiography and relationship with high-sensitivity troponin | 0.6 | 2 | Citations (PDF) |
| 910 | The Role of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Cerebrospinal Fluids for Screening of Acute Bacterial Meningitis | 0.4 | 16 | Citations (PDF) |
| 911 | Automonitoraggio glicemico nei pazienti diabetici | 0.5 | 1 | Citations (PDF) |
| 912 | Documento di consenso FCSA, SIMeL, SIBioC e CISMEL sul monitoraggio di laboratorio dei nuovi farmaci anticoagulanti orali | 0.5 | 1 | Citations (PDF) |
| 913 | Effects of vigorous mixing of blood vacuum tubes on laboratory test results | 1.9 | 31 | Citations (PDF) |
| 914 | Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department | 2.4 | 49 | Citations (PDF) |
| 915 | Challenges of serial troponin testing: An unfinished symphony | 2.3 | 6 | Citations (PDF) |
| 916 | Quality Impact on Diagnostic Blood Specimen Collection Using a New Device to Relieve Venipuncture Pain | 1.3 | 14 | Citations (PDF) |
| 917 | Epigenetic alteration: new insights moving from tissue to plasma – the example of PCDH10 promoter methylation in colorectal cancer | 5.7 | 51 | Citations (PDF) |
| 918 | Controlling Sources of Preanalytical Variability in Doping Samples: Challenges and Solutions | 1.2 | 12 | Citations (PDF) |
| 919 | The concentration of highly-sensitive troponin I is increased in patients with brain injury after mild head trauma | 2.3 | 10 | Citations (PDF) |
| 920 | Systematical assessment of serum indices does not impair efficiency of clinical chemistry testing: A multicenter study | 1.9 | 21 | Citations (PDF) |
| 921 | Evaluation of biological variation of glycated albumin (GA) and fructosamine in healthy subjects | 1.6 | 36 | Citations (PDF) |
| 922 | Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and troponin for early diagnosis of acute myocardial infarction | 1.9 | 54 | Citations (PDF) |
| 923 | Circulating microRNAs (miRs) for diagnosing acute myocardial infarction: Meta-analysis of available studies | 2.3 | 31 | Citations (PDF) |
| 924 | MicroRNAs for diagnosing myocardial infarction. Advantages and limitations | 2.3 | 4 | Citations (PDF) |
| 925 | Ischemia-modified albumin in the era of high-sensitivity troponin immunoassays: Useful or hype? | 1.3 | 1 | Citations (PDF) |
| 926 | Laboratory hemostasis: milestones in <i>Clinical Chemistry and Laboratory Medicine</i> | 2.4 | 26 | Citations (PDF) |
| 927 | Hemoglobin Point-of-Care Testing: The HemoCue System | 3.5 | 123 | Citations (PDF) |
| 928 | Evaluation of white blood cell count in peritoneal fluid with five different hemocytometers | 1.9 | 19 | Citations (PDF) |
| 929 | Interference from heterophilic antibodies in troponin testing. Case report and systematic review of the literature | 1.6 | 94 | Citations (PDF) |
| 930 | Influence of lean and fat mass on bone mineral density and on urinary stone risk factors in healthy women | 6.6 | 13 | Citations (PDF) |
| 931 | Pharmacotherapy of von Willebrand disease | 1.0 | 0 | Citations (PDF) |
| 932 | Assay Characteristics and Diagnostic Improvement from Contemporary to High-sensitivity Troponin I Immunoassays | 2.3 | 5 | Citations (PDF) |
| 933 | Evaluation of diagnostic accuracy of 75th percentile threshold for a contemporary sensitive and a high-sensitivity cardiac troponin I immunoassays | 2.3 | 2 | Citations (PDF) |
| 934 | Antiplatelet Therapy in Marathon Runners: More Harm than Benefits? | 2.3 | 3 | Citations (PDF) |
| 935 | Effects of acute exercise and xanthine oxidase inhibition on novel cardiovascular biomarkers | 4.2 | 18 | Citations (PDF) |
| 936 | Biomarkers of myocardial ischemia in the emergency room: cardiospecific troponin and beyond | 2.9 | 23 | Citations (PDF) |
| 937 | Role of Biomarkers in the Diagnosis of Mild Traumatic Brain Injury | 8.9 | 1 | Citations (PDF) |
| 938 | Anemia, heart failure and exercise training | 2.3 | 3 | Citations (PDF) |
| 939 | Lipaemic donations: Truth and consequences | 1.0 | 15 | Citations (PDF) |
| 940 | Assessment of neutrophil gelatinase-associated lipocalin and lactate dehydrogenase in peritoneal fluids for the screening of bacterial peritonitis | 1.6 | 19 | Citations (PDF) |
| 941 | Highly-sensitive troponin I in patients admitted to the emergency room with acute infections | 2.9 | 8 | Citations (PDF) |
| 942 | Intravenous iron therapy in patients with heart failure. A double-edged sword | 2.3 | 2 | Citations (PDF) |
| 943 | Prevention of hemolysis in blood samples collected from intravenous catheters | 1.9 | 39 | Citations (PDF) |
| 944 | Relationship between red blood cell distribution width and prognostic biomarkers in patients admitted to the emergency department with acute infections | 2.9 | 25 | Citations (PDF) |
| 945 | Pediatric reference values for urine particle quantification by using automated flow cytometer: Results of a multicenter study of Italian urinalysis group | 1.9 | 13 | Citations (PDF) |
| 946 | Proposta di una checklist per il prelievo di sangue venoso | 0.5 | 0 | Citations (PDF) |
| 947 | Brand of dipotassium EDTA vacuum tube as a new source of pre-analytical variability in routine haematology testing | 2.1 | 21 | Citations (PDF) |
| 948 | Massive Posttraumatic Bleeding: Epidemiology, Causes, Clinical Features, and Therapeutic Management | 2.6 | 11 | Citations (PDF) |
| 949 | Interference in Coagulation Testing: Focus on Spurious Hemolysis, Icterus, and Lipemia | 2.6 | 110 | Citations (PDF) |
| 950 | Influence of Residual Platelet Count on Routine Coagulation, Factor VIII, and Factor IX Testing in Postfreeze-Thaw Samples | 2.6 | 27 | Citations (PDF) |
| 951 | Problems and Solutions in Laboratory Testing for Hemophilia | 2.6 | 40 | Citations (PDF) |
| 952 | Glycogen phosphorylase isoenzyme BB in the diagnosis of acute myocardial infarction: a meta-analysis | 1.2 | 22 | Citations (PDF) |
| 953 | Reduction of gross hemolysis in catheter-drawn blood using Greiner Holdex® tube holder | 1.2 | 9 | Citations (PDF) |
| 954 | Serum Oxidant and Antioxidant Status Following an All-Out 21-km Run in Adolescent Runners Undergoing Professional Training—A One-Year Prospective Trial | 4.5 | 16 | Citations (PDF) |
| 955 | Novel and Emerging Therapies: Thrombus-Targeted Fibrinolysis | 2.6 | 32 | Citations (PDF) |
| 956 | Regulation in Hemostasis and Thrombosis: Part I—In Vitro Diagnostics | 2.6 | 34 | Citations (PDF) |
| 957 | Venous Thrombosis Associated with HMG-CoA Reductase Inhibitors | 2.6 | 40 | Citations (PDF) |
| 958 | Diagnosis and Management of Ischemic Heart Disease | 2.6 | 63 | Citations (PDF) |
| 959 | Evaluation of the Fully Automated Hematological Analyzer Sysmex XE-5000 for Flow Cytometric Analysis of Peritoneal Fluid | 3.5 | 14 | Citations (PDF) |
| 960 | Development of a novel, hemolysis-resistant reagent for assessment of α-amylase in biological fluids | 2.4 | 2 | Citations (PDF) |
| 961 | Preliminary evaluation of complete blood cell count on Mindray BC-6800 | 2.4 | 15 | Citations (PDF) |
| 962 | Carryover does not affect results of Beckman Coulter highly-sensitive-AccuTnI assay on Access 2 | 2.4 | 3 | Citations (PDF) |
| 963 | Personalized (laboratory) medicine: a bridge to the future | 2.4 | 16 | Citations (PDF) |
| 964 | Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation | 2.4 | 43 | Citations (PDF) |
| 965 | The order of draw: myth or science? | 2.4 | 40 | Citations (PDF) |
| 966 | Sodium citrate vacuum tubes validation | 1.0 | 30 | Citations (PDF) |
| 967 | The effective reduction of tourniquet application time after minor modification of the CLSI H03-A6 blood collection procedure | 1.2 | 35 | Citations (PDF) |
| 968 | Clinical Chemistry and Laboratory Medicine: progress and new challenges for our 50-year-old journal | 2.4 | 4 | Citations (PDF) |
| 969 | Testing volume is not synonymous of cost, value and efficacy in laboratory diagnostics | 2.4 | 22 | Citations (PDF) |
| 970 | False myths and legends in laboratory diagnostics | 2.4 | 11 | Citations (PDF) |
| 971 | Biomarker research and leading causes of death worldwide: a rather feeble relationship | 2.4 | 27 | Citations (PDF) |
| 972 | Survey of national guidelines, education and training on phlebotomy in 28 European countries: an original report by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PA) | 2.4 | 79 | Citations (PDF) |
| 973 | Anemia and Anysocytosis in the Emergency Department: A Cross-Sectional Investigation | 1.9 | 2 | Citations (PDF) |
| 974 | Analytical Evaluation of the Novel Helena V8 Capillary Electrophoresis System | 1.9 | 5 | Citations (PDF) |
| 975 | ANALYTICAL AND CLINICAL EVALUATION OF SYSMEX UF1000I FOR AUTOMATED SCREENING OF CEREBROSPINAL FLUIDS ANALITIČKA I KLINIČKA EVALUACIJA UREĐAJA SYSMEX UF1000I ZA AUTOMATSKI SKRINING CEREBROSPINALNIH TEČNOSTI | 1.9 | 8 | Citations (PDF) |
| 976 | Critical review and meta-analysis of spurious hemolysis in blood samples collected from intravenous catheters | 1.2 | 53 | Citations (PDF) |
| 977 | Avoidance to wipe alcohol before venipuncture is not a source of spurious hemolysis | 1.2 | 17 | Citations (PDF) |
| 978 | Evaluation of sample hemolysis in blood collected by S-MonovetteR using vacuum or aspiration mode | 1.2 | 19 | Citations (PDF) |
| 979 | Preanalytical quality improvement: in quality we trust | 2.4 | 183 | Citations (PDF) |
| 980 | The syndrome of the “obsessive-compulsory scientist”: a new mental disorder? | 2.4 | 5 | Citations (PDF) |
| 981 | Hemolysis-resistant reagent: another part of the puzzle for preventing errors in laboratory testing | 2.4 | 1 | Citations (PDF) |
| 982 | Influence of spurious hemolysis on blood gas analysis | 2.4 | 50 | Citations (PDF) |
| 983 | Serum gamma-glutamyltransferase and alanine aminotransferase levels are correlated with hematocrit in a general population of outpatients | 1.3 | 3 | Citations (PDF) |
| 984 | Continuous-Flow Automation and Hemolysis Index: A Crucial Combination | 3.5 | 21 | Citations (PDF) |
| 985 | Blood sample contamination by glucose-containing solutions: effects and identification | 2.1 | 12 | Citations (PDF) |
| 986 | Mean platelet volume in patients with ischemic heart disease | 1.0 | 16 | Citations (PDF) |
| 987 | The mean platelet volume is decreased in patients with mild head trauma and brain injury | 1.0 | 9 | Citations (PDF) |
| 988 | Counterpoint: highly-sensitive troponin immunoassays in the emergency department | 0.2 | 2 | Citations (PDF) |
| 989 | Incorrect order of draw could be mitigate the patient safety: a phlebotomy management case report | 1.2 | 29 | Citations (PDF) |
| 990 | Red blood cell distribution width and erythrocyte parameters in patients with brain injury after mild head trauma | 0.2 | 0 | Citations (PDF) |
| 991 | Ischemic heart disease in the emergency room: state of the art, innovation and research | 0.2 | 2 | Citations (PDF) |
| 992 | Association of red blood cell distribution width with plasma lipids in a general population of unselected outpatients | 0.6 | 40 | Citations (PDF) |
| 993 | Effects of Acute Exercise and Allopurinol Administration on Soluble Urokinase Plasminogen Activator Receptor (suPAR) | 0.4 | 11 | Citations (PDF) |
| 994 | Lack of an Association between Circulating Adiponectin Levels and Risk of Colorectal Adenoma | 0.4 | 6 | Citations (PDF) |
| 995 | Serum Creatinine Concentration and Creatinine-Based Estimation of Glomerular Filtration Rate in Athletes | 6.6 | 37 | Citations (PDF) |
| 996 | Bone Metabolism Markers in Sports Medicine | 6.6 | 148 | Citations (PDF) |
| 997 | Stability of Haematological Parameters and Its Relevance on the Athleteʼs Biological Passport Model | 6.6 | 29 | Citations (PDF) |
| 998 | Troponin I measured with a high sensitivity immunoassay is significantly increased after a half marathon run | 1.3 | 34 | Citations (PDF) |
| 999 | Quality Standards for Sample Processing, Transportation, and Storage in Hemostasis Testing | 2.6 | 133 | Citations (PDF) |
| 1000 | Hbmass for Anti-Doping Purposes Should be Assessed in Combination with Hemoglobin and Blood Volume | 1.8 | 4 | Citations (PDF) |
| 1001 | Quality Standards for Sample Collection in Coagulation Testing | 2.6 | 170 | Citations (PDF) |
| 1002 | Hemostatic Properties of the Lymph: Relationships with Occlusion and Thrombosis | 2.6 | 47 | Citations (PDF) |
| 1003 | Inherited disorders of blood coagulation | 4.1 | 31 | Citations (PDF) |
| 1004 | Patient Safety and Quality in Laboratory and Hemostasis Testing: A Renewed Loop? | 2.6 | 40 | Citations (PDF) |
| 1005 | Vitamin D, Thrombosis, and Hemostasis: More than Skin Deep | 2.6 | 69 | Citations (PDF) |
| 1006 | Coffee Intake and Cardiovascular Disease: Virtue Does Not Take Center Stage | 2.6 | 27 | Citations (PDF) |
| 1007 | Degradation of Troponin I in Serum or Plasma: Mechanisms, and Analytical and Clinical Implications | 2.6 | 29 | Citations (PDF) |
| 1008 | Acquired Inhibitors of Coagulation Factors: Part II | 2.6 | 60 | Citations (PDF) |
| 1009 | Biological variation and reference change values: an essential piece of the puzzle of laboratory testing | 2.4 | 26 | Citations (PDF) |
| 1010 | Serum but not urine concentration of neutrophil gelatinase-associated lipocalin is influenced by acute leukocyte variations | 1.5 | 17 | Citations (PDF) |
| 1011 | Variation of serum and urinary neutrophil gelatinase associated lipocalin (NGAL) after strenuous physical exercise | 2.4 | 41 | Citations (PDF) |
| 1012 | Phlebotomy, stat testing and laboratory organization: an intriguing relationship | 2.4 | 15 | Citations (PDF) |
| 1013 | Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: the case of copeptin | 2.4 | 34 | Citations (PDF) |
| 1014 | Mid-stream vs. first-voided urine collection by using automated analyzers for particle examination in healthy subjects: an Italian multicenter study | 2.4 | 23 | Citations (PDF) |
| 1015 | Is Phlebotomy Part of the Dark Side in the Clinical Laboratory Struggle for Quality? | 1.0 | 23 | Citations (PDF) |
| 1016 | Reference values and the journal: why the past is now present | 2.4 | 14 | Citations (PDF) |
| 1017 | Laboratory medicine and sports: between Scylla and Charybdis | 2.4 | 19 | Citations (PDF) |
| 1018 | Meat consumption and cancer risk: is the definition of red meat always suitable? | 10.2 | 3 | Citations (PDF) |
| 1019 | K<sub><b>3</b></sub>EDTA Vacuum Tubes Validation for Routine Hematological Testing | 2.2 | 21 | Citations (PDF) |
| 1020 | Primary blood tubes mixing: time for updated recommendations | 2.4 | 24 | Citations (PDF) |
| 1021 | Evaluation of NGAL Test™, a fully-automated neutrophil gelatinase-associated lipocalin (NGAL) immunoassay on Beckman Coulter AU 5822 | 2.4 | 36 | Citations (PDF) |
| 1022 | Serum concentration of neopterin on admission does not improve the diagnostic performance of highly-sensitive troponin I | 2.4 | 7 | Citations (PDF) |
| 1023 | Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL<sup>1)</sup> | 2.4 | 23 | Citations (PDF) |
| 1024 | Reference change values may need some improvement but are invaluable tools in laboratory medicine | 2.4 | 15 | Citations (PDF) |
| 1025 | Canine olfactory detection of cancer versus laboratory testing: myth or opportunity? | 2.4 | 73 | Citations (PDF) |
| 1026 | Physical Exercise as an Epigenetic Modulator | 2.2 | 81 | Citations (PDF) |
| 1027 | Influence of mechanical hemolysis of blood on two D-dimer immunoassays | 1.0 | 24 | Citations (PDF) |
| 1028 | Variation of activated partial thromboplastin time according to age and sex in a large population study | 1.0 | 5 | Citations (PDF) |
| 1029 | Discard tube for coagulation testing | 1.0 | 3 | Citations (PDF) |
| 1030 | Identification of Troponin Determinants for Improving its Diagnostic Performance in the Emergency Department | 0.8 | 16 | Citations (PDF) |
| 1031 | Hyperhomocysteinemia in health and disease: where we are now, and where do we go from here? | 2.4 | 34 | Citations (PDF) |
| 1032 | Current limitations and future perspectives of the Athlete Blood Passport | 2.0 | 12 | Citations (PDF) |
| 1033 | Paradoxical thrombosis, part 2: anticoagulant and antiplatelet therapy | 2.0 | 7 | Citations (PDF) |
| 1034 | Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT | 2.0 | 11 | Citations (PDF) |
| 1035 | Hemolysis, lipaemia and icterus in specimens for arterial blood gas analysis | 1.9 | 51 | Citations (PDF) |
| 1036 | Serum levels of protein S100B predict intracranial lesions in mild head injury | 1.9 | 39 | Citations (PDF) |
| 1037 | Evaluation of the analytical performances of the novel Beckman Coulter AU5800 | 1.9 | 28 | Citations (PDF) |
| 1038 | Different manufacturers of syringes: A new source of variability in blood gas, acid–base balance and related laboratory test? | 1.9 | 38 | Citations (PDF) |
| 1039 | Analytical evaluation of Sysmex UF-1000i for flow cytometric analysis of peritoneal fluid | 1.9 | 25 | Citations (PDF) |
| 1040 | Pathophysiology, clinics, diagnosis and treatment of heart involvement in carbon monoxide poisoning | 1.9 | 133 | Citations (PDF) |
| 1041 | Prostate-specific antigen (PSA) isoform p2PSA in prostate cancer screening: systematic review of current evidence and further perspectives | 0.5 | 1 | Citations (PDF) |
| 1042 | Biological therapies for von Willebrand disease | 3.1 | 36 | Citations (PDF) |
| 1043 | Laboratory diagnosis of acute pancreatitis: in search of the Holy Grail | 5.8 | 124 | Citations (PDF) |
| 1044 | The emerging role of biomarkers and bio-impedance in evaluating hydration status in patients with acute heart failure | 2.4 | 57 | Citations (PDF) |
| 1045 | Pre-analytical Variables in Coagulation Testing Associated With Diagnostic Errors in Hemostasis | 1.0 | 118 | Citations (PDF) |
| 1046 | ABO blood group, hypercoagulability, and cardiovascular and cancer risk | 5.8 | 132 | Citations (PDF) |
| 1047 | Mean platelet volume increases with aging in a large population study | 2.4 | 53 | Citations (PDF) |
| 1048 | Random plasma glucose measurement may improve the diagnostic specificity of highly sensitive troponin in the emergency department | 2.3 | 5 | Citations (PDF) |
| 1049 | Erythrocyte mechanical fragility is increased in patients with type 2 diabetes | 2.9 | 55 | Citations (PDF) |
| 1050 | The role of red blood cell distribution width in cardiovascular and thrombotic disorders | 2.4 | 212 | Citations (PDF) |
| 1051 | EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact | 2.4 | 120 | Citations (PDF) |
| 1052 | Laboratory networking and sample quality: a still relevant issue for patient safety | 2.4 | 35 | Citations (PDF) |
| 1053 | Incomplete filling of lithium heparin tubes affects the activity of creatine kinase and γ-glutamyltransferase | 2.1 | 16 | Citations (PDF) |
| 1054 | Influence of a Regular, Standardized Meal on Clinical Chemistry Analytes | 2.2 | 61 | Citations (PDF) |
| 1055 | Diagnostic significance of haematological testing in patients presenting at the Emergency Department | 0.2 | 2 | Citations (PDF) |
| 1056 | An Unusual Case of a Primary Blood Collection Tube with Floating Separator Gel | 2.8 | 23 | Citations (PDF) |
| 1057 | Neutrophil gelatinase-associated lipocalin (NGAL): the laboratory perspective | 2.4 | 35 | Citations (PDF) |
| 1058 | Predictable impact of the routine implementation of the CKD-EPI equation for estimating glomerular filtration rate by a simulation study | 0.5 | 0 | Citations (PDF) |
| 1059 | Achievement of a median door‐to‐balloon time of less than 90 minutes by implementation of organizational changes in the ‘Emergency Department to Cath Lab’ pathway: a 5‐year analysis | 1.8 | 6 | Citations (PDF) |
| 1060 | Intermittent hypobaric hypoxia applicability in myocardial infarction prevention and recovery | 4.1 | 16 | Citations (PDF) |
| 1061 | Evaluation of the current prognostic role of cardiogenic syncope | 3.2 | 8 | Citations (PDF) |
| 1062 | Serum Oxidant and Antioxidant Status in Adolescents Undergoing Professional Endurance Sports Training | 4.6 | 23 | Citations (PDF) |
| 1063 | Biomedical research platforms and their influence on article submissions and journal rankings: An update | 1.2 | 31 | Citations (PDF) |
| 1064 | Non-commutability of results of highly sensitive troponin I and T immunoassays | 1.2 | 6 | Citations (PDF) |
| 1065 | Preanalytical phase – a continuous challenge for laboratory professionals | 1.2 | 123 | Citations (PDF) |
| 1066 | Preanalytical management: serum vacuum tubes validation for routine clinical chemistry | 1.2 | 37 | Citations (PDF) |
| 1067 | The new oral anticoagulants and the future of haemostasis laboratory testing | 1.2 | 49 | Citations (PDF) |
| 1068 | Impact of the phlebotomy training based on CLSI/NCCLS H03-A6 – procedures for the collection of diagnostic blood | 1.2 | 54 | Citations (PDF) |
| 1069 | Closing the brain-to-brain loop in laboratory testing | 2.4 | 63 | Citations (PDF) |
| 1070 | Preanalytical quality improvement: from dream to reality | 2.4 | 304 | Citations (PDF) |
| 1071 | Arterial thrombus formation in cardiovascular disease | 37.5 | 289 | Citations (PDF) |
| 1072 | Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories | 5.8 | 176 | Citations (PDF) |
| 1073 | Hyperthyroidism and Venous Thrombosis: A Casual or Causal Association? A Systematic Literature Review | 1.9 | 60 | Citations (PDF) |
| 1074 | Screening and therapeutic management of lipoprotein(a) excess: Review of the epidemiological evidence, guidelines and recommendations | 1.6 | 20 | Citations (PDF) |
| 1075 | Human chorionic gonadotropin in pregnancy diagnostics | 1.6 | 62 | Citations (PDF) |
| 1076 | Ex-vivo red blood cells generation: A step ahead in transfusion medicine? | 2.9 | 15 | Citations (PDF) |
| 1077 | Significant variation of traditional markers of liver injury after a half-marathon run | 2.9 | 71 | Citations (PDF) |
| 1078 | Inflammatory biomarkers for the diagnosis, monitoring and follow-up of community-acquired pneumonia: Clinical evidence and perspectives | 2.9 | 38 | Citations (PDF) |
| 1079 | The health risks of acute exercise should also matter to internal medicine | 2.9 | 1 | Citations (PDF) |
| 1080 | Antisense therapy in the treatment of hypercholesterolemia | 2.9 | 14 | Citations (PDF) |
| 1081 | The usefulness of troponin testing in the diagnostics of non-thrombotic pulmonary embolism | 2.3 | 5 | Citations (PDF) |
| 1082 | p2PSA but not total and free PSA increases after myocardial infarction: Results of a preliminary investigation | 2.3 | 2 | Citations (PDF) |
| 1083 | High-Sensitive Troponin Testing and the “Runner's Syndrome” | 0.8 | 6 | Citations (PDF) |
| 1084 | Influence of hemolysis on troponin testing: studies on Beckman Coulter UniCel Dxl 800 Accu-TnI and overview of the literature | 2.4 | 19 | Citations (PDF) |
| 1085 | Influence of temperature and period of freezing on the generation of hemolysate and blood cell lysate | 1.9 | 13 | Citations (PDF) |
| 1086 | Inherited and acquired factor V deficiency | 1.0 | 55 | Citations (PDF) |
| 1087 | Laboratory testing of anticoagulants: the present and the future | 1.6 | 85 | Citations (PDF) |
| 1088 | A laboratory standpoint on the role of hemoglobin A1c for the diagnosis of diabetes in childhood: more doubts than certainties? | 4.5 | 22 | Citations (PDF) |
| 1089 | Erythropoietin and Myocardial Infarction | 2.8 | 1 | Citations (PDF) |
| 1090 | Glycoprotein IIb/IIIa Inhibitors: An Update on the Mechanism of Action and use of Functional Testing Methods to Assess Antiplatelet Efficacy | 1.6 | 37 | Citations (PDF) |
| 1091 | Letter to the Editor regarding “Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing” | 3.5 | 3 | Citations (PDF) |
| 1092 | Raccomandazioni di consenso SIBioC-SIMeL per la rilevazione e gestione dei campioni emolizzati e utilizzo dell’indice di emolisi | 0.5 | 6 | Citations (PDF) |
| 1093 | Unusual false‐positive case of urinary screening for buprenorphine | 2.8 | 9 | Citations (PDF) |
| 1094 | The significance of protein S-100B testing in cardiac arrest patients | 1.9 | 9 | Citations (PDF) |
| 1095 | Suitability of a transport box for blood sample shipment over a long period | 1.9 | 52 | Citations (PDF) |
| 1096 | Prevention of Venous Thromboembolism: Focus on Mechanical Prophylaxis | 2.6 | 63 | Citations (PDF) |
| 1097 | The Spectrum of Coagulation Abnormalities in Thyroid Disorders | 2.6 | 26 | Citations (PDF) |
| 1098 | Holiday Thrombosis | 2.6 | 14 | Citations (PDF) |
| 1099 | Obstructive Sleep Apnea Syndrome and Cardiovascular Diseases | 2.6 | 119 | Citations (PDF) |
| 1100 | Doping and Thrombosis in Sports | 2.6 | 34 | Citations (PDF) |
| 1101 | Thrombosis and Occlusion of Vascular Access in Hemodialyzed Patients | 2.6 | 26 | Citations (PDF) |
| 1102 | Venous Thromboembolism in Chronic Liver Disease | 2.6 | 12 | Citations (PDF) |
| 1103 | Blood cells characteristics as determinants of acute myocardial infarction | 2.4 | 41 | Citations (PDF) |
| 1104 | Prevalence of hemolytic specimens referred for arterial blood gas analysis | 2.4 | 35 | Citations (PDF) |
| 1105 | Athlete's biological passport: to test or not to test? | 2.4 | 16 | Citations (PDF) |
| 1106 | Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against? | 2.4 | 24 | Citations (PDF) |
| 1107 | Regulation of in vitro diagnostics (IVDs) for use in clinical diagnostic laboratories: towards the light or dark in clinical laboratory testing? | 2.4 | 11 | Citations (PDF) |
| 1108 | Analytical variability in sport hematology: its importance in an antidoping setting | 2.4 | 20 | Citations (PDF) |
| 1109 | Appropriate labelling of blood collection tubes: a step ahead towards patient’s safety | 2.4 | 29 | Citations (PDF) |
| 1110 | Comparison of conventional and highly-sensitive troponin I measurement in ultra-marathon runners | 2.0 | 16 | Citations (PDF) |
| 1111 | Anti-“negative-doping” testing: a new perspective in anti-doping research? | 2.0 | 3 | Citations (PDF) |
| 1112 | Cardiac troponins and physical exercise. It’s time to make a point | 1.2 | 45 | Citations (PDF) |
| 1113 | New ways to deal with known preanalytical issues: use of transilluminator instead of tourniquet for easing vein access and eliminating stasis on clinical biochemistry | 1.2 | 51 | Citations (PDF) |
| 1114 | Studies on in vitro hemolysis and utility of corrective formulas for reporting results on hemolyzed specimens | 1.2 | 37 | Citations (PDF) |
| 1115 | NT-proBNP Concentrations in Mountain Marathoners | 2.2 | 21 | Citations (PDF) |
| 1116 | Shortened activated partial thromboplastin time: causes and management | 1.0 | 62 | Citations (PDF) |
| 1117 | Epidemiological Association between Uric Acid Concentration in Plasma, Lipoprotein(a), and the Traditional Lipid Profile | 2.1 | 61 | Citations (PDF) |
| 1118 | Preanalytical variability: the dark side of the moon in blood doping screening | 2.0 | 28 | Citations (PDF) |
| 1119 | Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future | 2.0 | 103 | Citations (PDF) |
| 1120 | Discard Tubes Are Sometimes Necessary When Drawing Samples for HemostasisThe Authors’ Reply | 0.8 | 9 | Citations (PDF) |
| 1121 | Kinetics of highly sensitive troponin I and T after eccentric exercise | 2.4 | 6 | Citations (PDF) |
| 1122 | Interferences in red blood cell counting in urinalysis using evacuated tubes | 2.4 | 4 | Citations (PDF) |
| 1123 | Glycated hemoglobin (HbA1c): old dogmas, a new perspective? | 2.4 | 72 | Citations (PDF) |
| 1124 | Darwinian evolution or regression? The fate of laboratory professionals | 2.4 | 1 | Citations (PDF) |
| 1125 | Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features | 2.4 | 271 | Citations (PDF) |
| 1126 | Contemporary platelet function testing | 2.4 | 87 | Citations (PDF) |
| 1127 | The “Obamanomics”: a revolution in laboratory diagnostics | 2.4 | 5 | Citations (PDF) |
| 1128 | Laboratory testing in pharmacies | 2.4 | 30 | Citations (PDF) |
| 1129 | C-reactive protein and venous thromboembolism: causal or casual association? | 2.4 | 55 | Citations (PDF) |
| 1130 | Proteomic analysis of venous thromboembolism | 2.1 | 6 | Citations (PDF) |
| 1131 | Analytical Variability in Athletes Haematological Testing | 1.8 | 5 | Citations (PDF) |
| 1132 | Recombinant Activated Factor VII: Mechanisms of Action and Current Indications | 2.6 | 64 | Citations (PDF) |
| 1133 | Disseminated Intravascular Coagulation in Trauma Injuries | 2.6 | 29 | Citations (PDF) |
| 1134 | Autologous Platelet-Rich Plasma: A Revolution in Soft Tissue Sports Injury Management? | 1.9 | 76 | Citations (PDF) |
| 1135 | Disseminated Intravascular Coagulation in Burn Injury | 2.6 | 56 | Citations (PDF) |
| 1136 | Recombinant Factor VIII Concentrates | 2.6 | 43 | Citations (PDF) |
| 1137 | Biochemical markers of muscular damage | 2.4 | 680 | Citations (PDF) |
| 1138 | Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis? | 2.4 | 36 | Citations (PDF) |
| 1139 | Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps and colorectal cancers | 2.4 | 35 | Citations (PDF) |
| 1140 | Improving the post-analytical phase | 2.4 | 28 | Citations (PDF) |
| 1141 | Laboratory “incidentalomas”: Facts or fiction? | 2.9 | 6 | Citations (PDF) |
| 1142 | Glanzmann thrombasthenia: An update | 1.6 | 48 | Citations (PDF) |
| 1143 | Serum uric acid in top-level alpine skiers over four consecutive competitive seasons | 1.6 | 7 | Citations (PDF) |
| 1144 | Hyponatremia and Pseudohyponatremia: First, Do No Harm | 2.3 | 12 | Citations (PDF) |
| 1145 | Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients | 1.6 | 38 | Citations (PDF) |
| 1146 | Pathophysiology, clinics and diagnostics of non-thrombotic pulmonary embolism | 2.0 | 43 | Citations (PDF) |
| 1147 | Normobaric hypoxia and sports: the debate continues | 2.0 | 5 | Citations (PDF) |
| 1148 | Seasonal variations of haematological parameters in athletes | 2.0 | 44 | Citations (PDF) |
| 1149 | The measurement of cardiac troponins in patients undergoing major orthopaedic surgery | 1.9 | 1 | Citations (PDF) |
| 1150 | Total quality in laboratory diagnostics. It's time to think outside the box | 1.2 | 23 | Citations (PDF) |
| 1151 | Development of a preanalytical errors recording software | 1.2 | 10 | Citations (PDF) |
| 1152 | Quality in laboratory diagnostics: from theory to practice | 1.2 | 39 | Citations (PDF) |
| 1153 | Overview on patient safety in healthcare and laboratory diagnostics | 1.2 | 36 | Citations (PDF) |
| 1154 | Hemolysis detection and management of hemolysed specimens | 1.2 | 69 | Citations (PDF) |
| 1155 | Quality in extra-analytical phases of urinanalysis | 1.2 | 9 | Citations (PDF) |
| 1156 | Multicenter evaluation of the hemolysis index in automated clinical chemistry systems | 2.4 | 116 | Citations (PDF) |
| 1157 | Biomarkers of Myocardial Infarction in Patients Undergoing Gastrointestinal Cancer Surgery | 1.0 | 1 | Citations (PDF) |
| 1158 | Biological Influence of Physical Exercise on Hemostasis | 2.6 | 131 | Citations (PDF) |
| 1159 | Survey on the prevalence of hemolytic specimens in an academic hospital according to collection facility: opportunities for quality improvement | 2.4 | 45 | Citations (PDF) |
| 1160 | Hemolysis index: quality indicator or criterion for sample rejection? | 2.4 | 59 | Citations (PDF) |
| 1161 | Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes | 2.4 | 113 | Citations (PDF) |
| 1162 | Pharmacogenetics of vitamin K antagonists: useful or hype? | 2.4 | 32 | Citations (PDF) |
| 1163 | The impact factor for evaluating scientists: the good, the bad and the ugly | 2.4 | 17 | Citations (PDF) |
| 1164 | Laboratory Investigation of Thrombophilia: The Good, the Bad, and the Ugly | 2.6 | 93 | Citations (PDF) |
| 1165 | Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications | 2.4 | 38 | Citations (PDF) |
| 1166 | The Bidirectional Relationship of Cancer and Hemostasis and the Potential Role of Anticoagulant Therapy in Moderating Thrombosis and Cancer Spread | 2.6 | 40 | Citations (PDF) |
| 1167 | Unsuspected Triggers of Venous Thromboembolism—Trivial or Not So Trivial? | 2.6 | 38 | Citations (PDF) |
| 1168 | Lipoprotein(a) in late onset neonatal sepsis | 1.6 | 0 | Citations (PDF) |
| 1169 | Prostate-Specific Antigen, Prostate Cancer, and Disorders of Hemostasis | 2.6 | 16 | Citations (PDF) |
| 1170 | Prophylaxis in Congenital Hemophilia with Inhibitors: The Role of Recombinant Activated Factor VII | 2.6 | 18 | Citations (PDF) |
| 1171 | Recent Improvements in the Clinical Treatment of Coagulation Factor Inhibitors | 2.6 | 18 | Citations (PDF) |
| 1172 | Circadian Variation within Hemostasis: An Underrecognized Link between Biology and Disease? | 2.6 | 58 | Citations (PDF) |
| 1173 | Mental Depression and Cardiovascular Disease: A Multifaceted, Bidirectional Association | 2.6 | 145 | Citations (PDF) |
| 1174 | Measurement of morning saliva cortisol in athletes | 1.9 | 51 | Citations (PDF) |
| 1175 | Response to “NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men” | 4.2 | 0 | Citations (PDF) |
| 1176 | Epidemiological association between fasting plasma glucose and shortened APTT | 1.9 | 48 | Citations (PDF) |
| 1177 | Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics | 2.4 | 128 | Citations (PDF) |
| 1178 | Will “personalized medicine” need personalized laboratory approach? | 1.6 | 12 | Citations (PDF) |
| 1179 | Overview on self-monitoring of blood glucose | 1.6 | 120 | Citations (PDF) |
| 1180 | Governance of preanalytical variability: Travelling the right path to the bright side of the moon? | 1.6 | 53 | Citations (PDF) |
| 1181 | Laboratory assessment and perioperative management of patients on antiplatelet therapy: From the bench to the bedside | 1.6 | 34 | Citations (PDF) |
| 1182 | Cardiac troponin T during sickle cell crisis | 2.3 | 12 | Citations (PDF) |
| 1183 | D-Dimer Measurement and Laboratory Feedback | 0.8 | 18 | Citations (PDF) |
| 1184 | Development and implementation of an automatic system for verification, validation and delivery of laboratory test results | 2.4 | 37 | Citations (PDF) |
| 1185 | The importance of incident reporting in laboratory diagnostics | 1.3 | 14 | Citations (PDF) |
| 1186 | Anaphylaxis in patients with congenital bleeding disorders and inhibitors | 1.0 | 31 | Citations (PDF) |
| 1187 | Intermittent hypoxic training: doping or what? | 2.0 | 10 | Citations (PDF) |
| 1188 | Thyroid-associated autoimmune coagulation disorders | 2.0 | 17 | Citations (PDF) |
| 1189 | The role of ethnicity, age and gender in venous thromboembolism | 2.0 | 96 | Citations (PDF) |
| 1190 | Relationship between 24-h air pollution, emergency department admission and diagnosis of acute coronary syndrome | 2.0 | 3 | Citations (PDF) |
| 1191 | Relation Between Red Blood Cell Distribution Width and Inflammatory Biomarkers in a Large Cohort of Unselected Outpatients | 2.5 | 871 | Citations (PDF) |
| 1192 | Increased Mean Platelet Volume in Patients With Acute Coronary Syndromes | 2.5 | 51 | Citations (PDF) |
| 1193 | Relationship between thyroid status and renal function in a general population of unselected outpatients | 1.9 | 35 | Citations (PDF) |
| 1194 | The genetic basis of human athletic performance. Why are psychological components so often overlooked? | 3.4 | 15 | Citations (PDF) |
| 1195 | Prevalence and type of pre-analytical problems for inpatients samples in coagulation laboratory | 1.8 | 75 | Citations (PDF) |
| 1196 | Help me, Doctor! My D-dimer is raised | 4.1 | 86 | Citations (PDF) |
| 1197 | Acute variation of biochemical markers of muscle damage following a 21‐km, half‐marathon run | 1.3 | 85 | Citations (PDF) |
| 1198 | New strategies for doping control | 1.8 | 32 | Citations (PDF) |
| 1199 | Arm Blood Pressure Index and Lipoprotein(a) in Renal Transplant Recipients | 0.7 | 0 | Citations (PDF) |
| 1200 | Air pollution and coagulation testing: A new source of biological variability? | 2.4 | 29 | Citations (PDF) |
| 1201 | Endometriosis and oxidative stress—serum markers? | 3.0 | 1 | Citations (PDF) |
| 1202 | Inherited platelet disorders | 1.6 | 17 | Citations (PDF) |
| 1203 | The paradoxical relationship between serum uric acid and cardiovascular disease | 1.6 | 206 | Citations (PDF) |
| 1204 | Undergraduate education in Laboratory Medicine | 1.6 | 6 | Citations (PDF) |
| 1205 | Laboratory, clinical and therapeutic aspects of acquired hemophilia A | 1.6 | 60 | Citations (PDF) |
| 1206 | Quality Improvement in Laboratory Medicine: Extra-Analytical Issues | 1.1 | 46 | Citations (PDF) |
| 1207 | Relationship between red blood cell distribution width and kidney function tests in a large cohort of unselected outpatients | 1.3 | 152 | Citations (PDF) |
| 1208 | N-Terminal proB-type natriuretic peptide (NT-proBNP) concentrations in elite rugby players at rest and after active and passive recovery following strenuous training sessions | 2.4 | 18 | Citations (PDF) |
| 1209 | Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories | 2.4 | 388 | Citations (PDF) |
| 1210 | Reply to the letter by Carraro: appropriate actions in the detection of haemolytic specimens | 2.4 | 3 | Citations (PDF) |
| 1211 | Pharmacy-based laboratory services: past or future and risk or opportunity? | 2.4 | 6 | Citations (PDF) |
| 1212 | Frequency and type of preanalytical errors in a laboratory medicine department in India | 2.4 | 18 | Citations (PDF) |
| 1213 | Acute Variation of Osteocalcin and Parathyroid Hormone in Athletes after Running a Half-Marathon | 1.1 | 15 | Citations (PDF) |
| 1214 | Sudden cardiac death: Prevalence, pathogenesis, and prevention | 4.1 | 32 | Citations (PDF) |
| 1215 | Doping in competition or doping in sport? | 4.1 | 58 | Citations (PDF) |
| 1216 | Non-homogeneous separation of triglycerides, γ-glutamyltransferase, C-reactive protein and lactate dehydrogenase after centrifugation of lithium-heparin tubes | 2.4 | 4 | Citations (PDF) |
| 1217 | Air Pollution and Sports Performance in Beijing | 1.8 | 30 | Citations (PDF) |
| 1218 | Detection of duplicates and redundancies. A major responsibility of peer-reviewers? | 2.4 | 5 | Citations (PDF) |
| 1219 | The use of recombinant activated factor VII in platelet-associated bleeding | 1.4 | 9 | Citations (PDF) |
| 1220 | Updates on improvement of human athletic performance: focus on world records in athletics | 4.1 | 50 | Citations (PDF) |
| 1221 | Switch off the light on cycling, switch off the light on doping | 11.2 | 9 | Citations (PDF) |
| 1222 | Glycaemic Control in Athletes | 1.8 | 23 | Citations (PDF) |
| 1223 | Acute Variation of Estimated Glomerular Filtration Rate Following a Half-Marathon Run | 1.8 | 37 | Citations (PDF) |
| 1224 | Comparison of creatinine-based estimations of glomerular filtration rate in endurance athletes at rest | 2.4 | 18 | Citations (PDF) |
| 1225 | Influence of acute physical exercise on emerging muscular biomarkers | 2.4 | 43 | Citations (PDF) |
| 1226 | Genomics and Sports: Building a Bridge Towards a Rational and Personalized Training Framework | 1.8 | 5 | Citations (PDF) |
| 1227 | Preanalytical and Postanalytical Variables: The Leading Causes of Diagnostic Error in Hemostasis? | 2.6 | 160 | Citations (PDF) |
| 1228 | Pathogenesis of Venous Thromboembolism: When the Cup Runneth Over | 2.6 | 129 | Citations (PDF) |
| 1229 | Activated Partial Thromboplastin Time: New Tricks for an Old Dogma | 2.6 | 85 | Citations (PDF) |
| 1230 | A Critical Review on the Use of Recombinant Factor VIIa in Life-Threatening Obstetric Postpartum Hemorrhage | 2.6 | 84 | Citations (PDF) |
| 1231 | Comments on Delanghe and Joyner's Editorial “Testing for recombinant human erythropoietin” | 2.9 | 3 | Citations (PDF) |
| 1232 | Prevalence of Folic Acid and Vitamin B12 Deficiencies in Patients With Thyroid Disorders | 0.8 | 21 | Citations (PDF) |
| 1233 | Plasma .GAMMA.-glutamyl Transferase Activity Predicts Homocysteine Concentration in a Large Cohort of Unselected Outpatients | 0.9 | 7 | Citations (PDF) |
| 1234 | Acquired factor VIII inhibitorsBlood, 2008, 112, 250-255 | 4.2 | 267 | Citations (PDF) |
| 1235 | Sudden Cardiac Death in Young Athletes | 0.9 | 39 | Citations (PDF) |
| 1236 | Influence of stable, long-term treatment with phenobarbital on the activity of serum alanine aminotransferase and γ-glutamyltransferase | 2.1 | 12 | Citations (PDF) |
| 1237 | Aspirin ‘responsiveness’, ‘nonresponsiveness’ or ‘resistance’: a putative role for von Willebrand factor? | 1.0 | 6 | Citations (PDF) |
| 1238 | Dishomogeneous separation of citrated plasma in primary collection tubes for routine coagulation testing | 1.0 | 4 | Citations (PDF) |
| 1239 | Cardiac biomarkers in pulmonary embolism | 4.2 | 11 | Citations (PDF) |
| 1240 | Antithrombotic prophylaxis in patients with von Willebrand disease undergoing major surgery: when is it necessary? | 2.0 | 20 | Citations (PDF) |
| 1241 | Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients | 2.0 | 30 | Citations (PDF) |
| 1242 | Dark chocolate: consumption for pleasure or therapy? | 2.0 | 23 | Citations (PDF) |
| 1243 | Influence of Sampling Time and Ultrafiltration Coefficient of the Dialysis Membrane on Cardiac Troponin I and T | 2.5 | 37 | Citations (PDF) |
| 1244 | No Correlation Between Lipoprotein(a) and Biochemical Markers of Renal Function in the General Population | 2.5 | 1 | Citations (PDF) |
| 1245 | Changes in technical regulations and drivers' safety in top-class motor sports | 11.2 | 10 | Citations (PDF) |
| 1246 | How many troponins should we measure to get a clinically significant result? | 0.5 | 1 | Citations (PDF) |
| 1247 | Standardization of ischemia-modified albumin testing: adjustment for serum albumin | 2.4 | 89 | Citations (PDF) |
| 1248 | Evaluation of Different Mixing Procedures for K2 EDTA Primary Samples on Hematological Testing | 1.0 | 14 | Citations (PDF) |
| 1249 | Preparation of a Quality Sample: Effect of Centrifugation Time on Stat Clinical Chemistry Testing | 1.0 | 19 | Citations (PDF) |
| 1250 | Diagnostic approach to inherited bleeding disorders | 2.4 | 33 | Citations (PDF) |
| 1251 | One hundred years of laboratory testing and patient safety | 2.4 | 21 | Citations (PDF) |
| 1252 | Recommendations for detection and management of unsuitable samples in clinical laboratories | 2.4 | 101 | Citations (PDF) |
| 1253 | Increased D-dimer value and occult cancer in the absence of detectable thrombosis | 4.1 | 19 | Citations (PDF) |
| 1254 | Lipoprotein(a), athero-thrombosis and longevity. A historical paradox finally elucidated? | 4.1 | 4 | Citations (PDF) |
| 1255 | Is the activated partial thromboplastin time suitable to screen for von Willebrand factor deficiencies? | 1.0 | 6 | Citations (PDF) |
| 1256 | Influence of primary sample mixing on routine coagulation testing | 1.0 | 13 | Citations (PDF) |
| 1257 | Recent acquisitions in acquired and congenital von Willebrand disorders | 1.6 | 20 | Citations (PDF) |
| 1258 | The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement | 1.6 | 19 | Citations (PDF) |
| 1259 | Relationship between γ-glutamyltransferase, lipids and lipoprotein(a) in the general population | 1.6 | 28 | Citations (PDF) |
| 1260 | Lipoprotein[a] and cancer: Anti-neoplastic effect besides its cardiovascular potency | 9.8 | 46 | Citations (PDF) |
| 1261 | Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte-platelet aggregates | 2.3 | 18 | Citations (PDF) |
| 1262 | Ginkgo biloba, inflammation and lipoprotein(a) | 1.6 | 16 | Citations (PDF) |
| 1263 | National survey on critical values reporting in a cohort of Italian laboratories | 2.4 | 36 | Citations (PDF) |
| 1264 | The Role Of von Willebrand Factor In Hemorrhagic And Thrombotic Disorders | 5.8 | 33 | Citations (PDF) |
| 1265 | Risk management in the preanalytical phase of laboratory testing | 2.4 | 146 | Citations (PDF) |
| 1266 | The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes | 2.4 | 238 | Citations (PDF) |
| 1267 | Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur | 2.8 | 15 | Citations (PDF) |
| 1268 | Influence of haemodialysis on high-sensitivity C-reactive protein, lipoprotein(a), apolipoproteins A and B | 1.9 | 5 | Citations (PDF) |
| 1269 | Prophylaxis in von Willebrand disease | 1.5 | 14 | Citations (PDF) |
| 1270 | Pathogenesis, clinical and laboratory aspects of thrombosis in cancer | 2.0 | 57 | Citations (PDF) |
| 1271 | Routine coagulation tests in newborn and young infants | 2.0 | 25 | Citations (PDF) |
| 1272 | Measurement of Elecsys NT-proBNP in serum, K2 EDTA and heparin plasma | 1.9 | 6 | Citations (PDF) |
| 1273 | Diagnostic value of D-dimer measurement in patients referred to the emergency department with suspected myocardial ischemia | 2.0 | 30 | Citations (PDF) |
| 1274 | Higher morning serum cortisol level predicts increased fibrinogen but not shortened APTT | 2.0 | 15 | Citations (PDF) |
| 1275 | Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma | 2.0 | 14 | Citations (PDF) |
| 1276 | Biochemical correlates of lipoprotein(a) in a general adult population. Possible implications for cardiovascular risk assessment | 2.0 | 7 | Citations (PDF) |
| 1277 | Platelets and lipoprotein(a) in retinal vein occlusion: Mutual targets for aspirin therapy | 4.2 | 5 | Citations (PDF) |
| 1278 | Inherited Thrombophilia | 5.8 | 61 | Citations (PDF) |
| 1279 | Biochemistry, Physiology, and Complications of Blood Doping: Facts and Speculation | 5.8 | 53 | Citations (PDF) |
| 1280 | Preanalytic Error Tracking in a Laboratory Medicine Department: Results of a 1-Year Experience | 1.1 | 96 | Citations (PDF) |
| 1281 | Lipoprotein[a] and the lipid profile in patients with systemic sclerosis | 1.6 | 38 | Citations (PDF) |
| 1282 | Influence of physical exercise and relationship with biochemical variables of NT-pro-brain natriuretic peptide and ischemia modified albumin | 1.6 | 42 | Citations (PDF) |
| 1283 | Managing transferability of laboratory data | 1.6 | 31 | Citations (PDF) |
| 1284 | Albumin cobalt binding and ischemia modified albumin generation: An endogenous response to ischemia? | 2.3 | 106 | Citations (PDF) |
| 1285 | Cardiospecific troponins in non-ischemic cardiological pathologies | 0.2 | 1 | Citations (PDF) |
| 1286 | Influence of the needle bore size on platelet count and routine coagulation testing | 1.0 | 60 | Citations (PDF) |
| 1287 | Quality and reliability of routine coagulation testing: can we trust that sample? | 1.0 | 71 | Citations (PDF) |
| 1288 | Plasma D-dimer variation following elective orthopedic surgery | 1.0 | 1 | Citations (PDF) |
| 1289 | Potential value for new diagnostic markers in the early recognition of acute coronary syndromes | 1.3 | 81 | Citations (PDF) |
| 1290 | Title is missing! | 2.1 | 9 | Citations (PDF) |
| 1291 | Title is missing! | 2.1 | 7 | Citations (PDF) |
| 1292 | Title is missing! | 2.1 | 67 | Citations (PDF) |
| 1293 | Title is missing! | 2.5 | 67 | Citations (PDF) |
| 1294 | Von Willebrand factor and thrombosis | 1.5 | 81 | Citations (PDF) |
| 1295 | Health benefits of physical activity | 1.3 | 12 | Citations (PDF) |
| 1296 | The Influence of the Tourniquet Time on Hematological Testing for Antidoping Purposes | 1.8 | 23 | Citations (PDF) |
| 1297 | Evaluation of four portable self-monitoring blood glucose meters | 2.0 | 13 | Citations (PDF) |
| 1298 | Influence of Centrifuge Temperature on Routine Coagulation Testing | 1.1 | 17 | Citations (PDF) |
| 1299 | National survey on the pre-analytical variability in a representative cohort of Italian laboratories | 2.4 | 16 | Citations (PDF) |
| 1300 | Evaluation of cardiac involvement following major orthopedic surgery | 2.4 | 18 | Citations (PDF) |
| 1301 | Blood transfusions in athletes. Old dogmas, new tricks | 2.4 | 33 | Citations (PDF) |
| 1302 | Comparison of the lipid profile and lipoprotein(a) between sedentary and highly trained subjects | 2.4 | 56 | Citations (PDF) |
| 1303 | Preanalytical variability: the dark side of the moon in laboratory testing | 2.4 | 334 | Citations (PDF) |
| 1304 | Influence of hemolysis on routine clinical chemistry testing | 2.4 | 292 | Citations (PDF) |
| 1305 | Preanalytical variability: the dark side of the moon in laboratory testing / Präanalytische Variabilität: die Schattenseite klinischer Laboruntersuchungen | 0.0 | 1 | Citations (PDF) |
| 1306 | Influence of the needle bore size used for collecting venous blood samples on routine clinical chemistry testing | 2.4 | 51 | Citations (PDF) |
| 1307 | Relation between serum creatinine and body mass index in elite athletes of different sport disciplines * Commentary | 11.2 | 69 | Citations (PDF) |
| 1308 | Interference of Blood Cell Lysis on Routine Coagulation Testing | 2.5 | 70 | Citations (PDF) |
| 1309 | The Skilled Phlebotomist | 2.5 | 9 | Citations (PDF) |
| 1310 | Influence of two different buffered sodium citrate concentrations on coagulation testing | 1.0 | 15 | Citations (PDF) |
| 1311 | Stability of blood cell counts, hematologic parameters and reticulocytes indexes on the Advia A120 hematologic analyzer | 2.3 | 66 | Citations (PDF) |
| 1312 | Preanalytical variability in laboratory testing: influence of the blood drawing technique | 2.4 | 49 | Citations (PDF) |
| 1313 | Influence of short-term venous stasis on clinical chemistry testing | 2.4 | 63 | Citations (PDF) |
| 1314 | High-workload endurance training may increase serum ischemia-modified albumin concentrations | 2.4 | 39 | Citations (PDF) |
| 1315 | Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls | 2.4 | 53 | Citations (PDF) |
| 1316 | Effect of Specimen Collection on Routine Coagulation Assays and D-Dimer Measurement | 1.1 | 42 | Citations (PDF) |
| 1317 | New Scenarios in Antidoping Research | 1.1 | 9 | Citations (PDF) |
| 1318 | Lipoprotein(a): An Emerging Cardiovascular Risk Factor | 5.8 | 64 | Citations (PDF) |
| 1319 | Prothrombotic effects and clinical implications of third-generation oral contraceptives use | 1.0 | 8 | Citations (PDF) |
| 1320 | Influence of the ABO Blood Type on the Platelet Function Analyzer PFA-100 | 4.2 | 46 | Citations (PDF) |
| 1321 | Laboratory Screening for Abnormalities of Primary Hemostasis | 1.1 | 7 | Citations (PDF) |
| 1322 | Establishment of reference values for the PFA-100 platelet function analyzer in pediatrics | 3.0 | 17 | Citations (PDF) |
| 1323 | Biochemical Risk Factors for Cardiovascular Disease in an Aged Male Population: Emerging Vascular Pathogens | 2.3 | 7 | Citations (PDF) |
| 1324 | Laboratory Screening for Erythropoietin Abuse in Sport: an Emerging Challenge | 2.4 | 22 | Citations (PDF) |
| 1325 | Lipoprotein(a): from ancestral benefit to modern pathogen? | 0.5 | 70 | Citations (PDF) |
| 1326 | Biochemical risk factors and patient's outcome: the case of lipoprotein(a) | 1.6 | 25 | Citations (PDF) |
| 1327 | Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response | 1.6 | 40 | Citations (PDF) |
| 1328 | Paradoxical behaviour of lyophilised commercial control materials for CK and CK-MB assays after reconstitution at either 4°C or 24°C | 1.6 | 4 | Citations (PDF) |
| 1329 | Platelet count in EDTA‐dependent pseudothrombocytopenia | 1.9 | 9 | Citations (PDF) |
| 1330 | Advantages of a New Anticoagulant in Routine Hematology on the Coulter Counter® S-Plus STKR Analyzer | 0.8 | 13 | Citations (PDF) |
| 1331 | Thromboprophylaxis in outpatients with COVID-19: a safe bet or tilting at windmills? | 1.2 | 2 | Citations (PDF) |
| 1332 | Accuracy of screening for hemolysis in plasma samples using a commercial urine dipstick | 1.0 | 0 | Citations (PDF) |
| 1333 | Epidemiology of cycling road injuries-related deaths | 0.2 | 0 | Citations (PDF) |
